ONTOLOGY REPORT - ANNOTATIONS
| Term: | diethylstilbestrol |
|
| Accession: | CHEBI:41922
|
browse the term
|
| Definition: | An estrogen that has formula C18H20O2. |
| Synonyms: | exact_synonym: | 4,4'-(3E)-hex-3-ene-3,4-diyldiphenol |
| | related_synonym: | (E)-3,4-bis(4-hydroxyphenyl)-3-hexene; (E)-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol; 4,4'-dihydroxy-alpha,beta-diethylstilbene; C18H20O2; CC\\C(c1ccc(O)cc1)=C(\\CC)c1ccc(O)cc1; Distilbene; InChI=1S/C18H20O2/c1-3-17(13-5-9-15(19)10-6-13)18(4-2)14-7-11-16(20)12-8-14/h5-12,19-20H,3-4H2,1-2H3/b18-17+; InChIKey=RGLYKWWBQGJZGM-ISLYRVAYSA-N; alpha,alpha'-diethyl-(E)-4,4'-stilbenediol; diethylstilbestrolum; dietilestilbestrol; trans-4,4'-(1,2-diethyl-1,2-ethenediyl)bisphenol; trans-Diethylstilbesterol; trans-Diethylstilbestrol; trans-Diethylstilboesterol |
| | alt_id: | CHEBI:41920; CHEBI:4531 |
| | xref_casrn: | 56-53-1 |
| | xref: | ChEMBL:100860 "ChEMBL COMPOUND"; ChemIDplus:2056095 "Beilstein Registry Number"; ChemIDplus:56-53-1 "CAS Registry Number"; DrugBank:DB00255 "DrugBank"; KEGG COMPOUND:56-53-1 "CAS Registry Number"; KEGG COMPOUND:C07620 "KEGG COMPOUND"; KEGG DRUG:D00577 "KEGG DRUG" |
| | xref_mesh: | MESH:D004054 |
| | xref: | NIST Chemistry WebBook:56-53-1 "CAS Registry Number"; Wikipedia:Diethylstilbestrol "Wikipedia" |
|
|
diethylstilbestrol
|
| G |
Aard |
alanine and arginine rich domain containing protein |
|
decreases expression |
ISO |
7 |
88,346,189 |
88,351,030 |
RGD:6480464 |
CTD |
| G |
Abcb1a |
ATP-binding cassette, sub-family B (MDR/TAP), member 1A |
|
decreases expression |
ISO |
4 |
21,709,855 |
21,796,628 |
RGD:6480464 |
CTD |
| G |
Abcc3 |
ATP-binding cassette, subfamily C (CFTR/MRP), member 3 |
|
decreases expression |
ISO |
10 |
82,986,552 |
83,030,799 |
RGD:6480464 |
CTD |
| G |
Abp1 |
amiloride binding protein 1 (amine oxidase, copper-containing) |
|
increases expression |
ISO |
4 |
76,957,477 |
76,977,643 |
RGD:6480464 |
CTD |
| G |
Aco1 |
aconitase 1, soluble |
|
increases expression |
EXP |
5 |
57,536,675 |
57,591,765 |
RGD:6480464 |
CTD |
| G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
|
increases expression |
EXP |
1 |
261,554,383 |
261,599,373 |
RGD:6480464 |
CTD |
| G |
Acss1 |
acyl-CoA synthetase short-chain family member 1 |
|
increases expression |
ISO |
3 |
141,259,016 |
141,308,871 |
RGD:6480464 |
CTD |
| G |
Acta1 |
actin, alpha 1, skeletal muscle |
|
decreases expression |
ISO |
19 |
54,081,496 |
54,084,508 |
RGD:6480464 |
CTD |
| G |
Actb |
actin, beta |
|
decreases expression |
ISO |
12 |
12,047,070 |
12,050,040 |
RGD:6480464 |
CTD |
| G |
Adcy1 |
adenylate cyclase 1 (brain) |
|
increases expression |
ISO |
14 |
87,812,256 |
87,923,402 |
RGD:6480464 |
CTD |
| G |
Adcy6 |
adenylate cyclase 6 |
|
decreases expression |
ISO |
7 |
137,339,933 |
137,360,020 |
RGD:6480464 |
CTD |
| G |
Adh1 |
alcohol dehydrogenase 1 (class I) |
|
decreases expression |
ISO |
2 |
235,799,396 |
235,811,584 |
RGD:6480464 |
CTD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
increases expression |
EXP |
11 |
79,908,291 |
79,911,065 |
RGD:6480464 |
CTD |
| G |
Adm2 |
adrenomedullin 2 |
|
increases expression |
EXP |
7 |
127,620,056 |
127,621,802 |
RGD:6480464 |
CTD |
| G |
Adora1 |
adenosine A1 receptor |
|
increases expression |
ISO |
13 |
47,160,292 |
47,192,804 |
RGD:6480464 |
CTD |
| G |
Adprh |
ADP-ribosylarginine hydrolase |
|
increases expression |
ISO |
11 |
64,079,175 |
64,085,514 |
RGD:6480464 |
CTD |
| G |
Adra2c |
adrenoceptor alpha 2C |
|
decreases expression |
ISO |
14 |
81,107,907 |
81,109,610 |
RGD:6480464 |
CTD |
| G |
Aebp1 |
AE binding protein 1 |
|
increases expression |
EXP |
14 |
86,525,748 |
86,535,664 |
RGD:6480464 |
CTD |
| G |
Aff3 |
AF4/FMR2 family, member 3 |
|
increases expression |
ISO |
9 |
37,121,330 |
37,516,836 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
multiple interactions |
ISO |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
affects binding |
EXP |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Afp |
alpha-fetoprotein |
|
multiple interactions |
EXP |
14 |
19,092,563 |
19,110,728 |
RGD:6480464 |
CTD |
| G |
Agr2 |
anterior gradient 2 homolog (Xenopus laevis) |
|
multiple interactions |
ISO |
6 |
54,695,633 |
54,716,858 |
RGD:6480464 |
CTD |
| G |
Agtr1b |
angiotensin II receptor, type 1b |
|
decreases expression |
EXP |
2 |
105,503,269 |
105,602,591 |
RGD:6480464 |
CTD |
| G |
Agtr2 |
angiotensin II receptor, type 2 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Agtrap |
angiotensin II receptor-associated protein |
|
increases expression |
ISO |
5 |
165,154,252 |
165,164,570 |
RGD:6480464 |
CTD |
| G |
Ahr |
aryl hydrocarbon receptor |
|
decreases expression |
ISO |
6 |
54,205,104 |
54,240,268 |
RGD:6480464 |
CTD |
| G |
Akap12 |
A kinase (PRKA) anchor protein 12 |
|
increases expression |
ISO |
1 |
34,979,039 |
35,068,763 |
RGD:6480464 |
CTD |
| G |
Akap8l |
A kinase (PRKA) anchor protein 8-like |
|
decreases expression |
ISO |
7 |
12,889,649 |
12,919,236 |
RGD:6480464 |
CTD |
| G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
increases expression |
ISO |
17 |
77,269,626 |
77,286,521 |
RGD:6480464 |
CTD |
| G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
multiple interactions |
ISO |
17 |
77,269,626 |
77,286,521 |
RGD:6480464 |
CTD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
increases phosphorylation |
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:6480464 |
CTD |
| G |
Aktip |
AKT interacting protein |
|
increases expression |
ISO |
19 |
17,035,220 |
17,045,096 |
RGD:6480464 |
CTD |
| G |
Alcam |
activated leukocyte cell adhesion molecule |
|
increases expression |
ISO |
11 |
49,424,243 |
49,630,071 |
RGD:6480464 |
CTD |
| G |
Aldoa |
aldolase A, fructose-bisphosphate |
|
increases expression |
ISO |
1 |
185,970,658 |
185,974,615 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
increases expression |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alpl |
alkaline phosphatase, liver/bone/kidney |
|
increases expression |
ISO |
5 |
156,501,739 |
156,558,727 |
RGD:6480464 |
CTD |
| G |
Alppl2 |
alkaline phosphatase, placental-like 2 |
|
increases expression |
ISO |
9 |
85,873,702 |
85,876,375 |
RGD:6480464 |
CTD |
| G |
Ambp |
alpha-1-microglobulin/bikunin precursor |
|
increases expression |
ISO |
5 |
80,119,742 |
80,129,962 |
RGD:6480464 |
CTD |
| G |
Ankh |
ankylosis, progressive homolog (mouse) |
|
increases expression |
ISO |
2 |
79,289,427 |
79,418,518 |
RGD:6480464 |
CTD |
| G |
Ano1 |
anoctamin 1, calcium activated chloride channel |
|
increases expression |
ISO |
1 |
205,018,529 |
205,166,049 |
RGD:6480464 |
CTD |
| G |
Anpep |
alanyl (membrane) aminopeptidase |
|
increases expression |
ISO |
1 |
135,600,751 |
135,619,208 |
RGD:6480464 |
CTD |
| G |
Anxa3 |
annexin A3 |
|
increases expression |
ISO |
14 |
14,245,112 |
14,297,100 |
RGD:6480464 |
CTD |
| G |
Ap1b1 |
adaptor-related protein complex 1, beta 1 subunit |
|
increases expression |
EXP |
14 |
85,663,840 |
85,695,487 |
RGD:6480464 |
CTD |
| G |
Ap2b1 |
adaptor-related protein complex 2, beta 1 subunit |
|
increases expression |
ISO |
10 |
71,386,233 |
71,488,000 |
RGD:6480464 |
CTD |
| G |
Apex1 |
APEX nuclease (multifunctional DNA repair enzyme) 1 |
|
increases expression |
EXP |
15 |
26,904,124 |
26,906,224 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
increases expression |
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Apoe |
apolipoprotein E |
|
decreases expression |
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:6480464 |
CTD |
| G |
Aqp3 |
aquaporin 3 |
|
increases expression |
ISO |
5 |
58,501,642 |
58,507,159 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases activity |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases expression |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects binding |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases expression |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
multiple interactions |
ISO |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
affects binding |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Ar |
androgen receptor |
|
decreases expression |
EXP |
X |
85,949,507 |
86,119,199 |
RGD:6480464 |
CTD |
| G |
Arg1 |
arginase, liver |
|
increases expression |
ISO |
1 |
20,998,894 |
21,011,275 |
RGD:6480464 |
CTD |
| G |
Arhgap15 |
Rho GTPase activating protein 15 |
|
increases expression |
EXP |
3 |
24,256,620 |
24,389,618 |
RGD:6480464 |
CTD |
| G |
Arhgdia |
Rho GDP dissociation inhibitor (GDI) alpha |
|
decreases expression |
ISO |
10 |
109,967,771 |
109,971,260 |
RGD:6480464 |
CTD |
| G |
Arhgdia |
Rho GDP dissociation inhibitor (GDI) alpha |
|
increases expression |
ISO |
10 |
109,967,771 |
109,971,260 |
RGD:6480464 |
CTD |
| G |
Arhgdib |
Rho, GDP dissociation inhibitor (GDI) beta |
|
decreases expression |
ISO |
4 |
173,967,842 |
173,986,494 |
RGD:6480464 |
CTD |
| G |
Arih2 |
ariadne homolog 2 (Drosophila) |
|
increases expression |
EXP |
8 |
113,647,000 |
113,705,922 |
RGD:6480464 |
CTD |
| G |
Arl4d |
ADP-ribosylation factor-like 4D |
|
increases expression |
ISO |
10 |
90,700,469 |
90,702,625 |
RGD:6480464 |
CTD |
| G |
Arpc1b |
actin related protein 2/3 complex, subunit 1B |
|
increases expression |
ISO |
12 |
9,796,269 |
9,803,639 |
RGD:6480464 |
CTD |
| G |
Asrgl1 |
asparaginase like 1 |
|
increases expression |
ISO |
1 |
211,788,145 |
211,808,943 |
RGD:6480464 |
CTD |
| G |
Ass1 |
argininosuccinate synthase 1 |
|
increases expression |
ISO |
3 |
10,578,717 |
10,622,332 |
RGD:6480464 |
CTD |
| G |
Atf3 |
activating transcription factor 3 |
|
increases expression |
EXP |
13 |
107,191,622 |
107,223,850 |
RGD:6480464 |
CTD |
| G |
Atf4 |
activating transcription factor 4 (tax-responsive enhancer element B67) |
|
increases expression |
EXP |
7 |
118,537,718 |
118,538,994 |
RGD:6480464 |
CTD |
| G |
Atp10d |
ATPase, class V, type 10D |
|
increases expression |
EXP |
14 |
38,340,037 |
38,433,736 |
RGD:6480464 |
CTD |
| G |
Atp1b1 |
ATPase, Na+/K+ transporting, beta 1 polypeptide |
|
decreases expression |
ISO |
13 |
80,214,056 |
80,234,576 |
RGD:6480464 |
CTD |
| G |
Atp1b3 |
ATPase, Na+/K+ transporting, beta 3 polypeptide |
|
increases expression |
EXP |
8 |
101,405,877 |
101,437,757 |
RGD:6480464 |
CTD |
| G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
|
decreases expression |
EXP |
7 |
36,493,661 |
36,600,280 |
RGD:6480464 |
CTD |
| G |
Atp2b1 |
ATPase, Ca++ transporting, plasma membrane 1 |
|
increases expression |
EXP |
7 |
36,493,661 |
36,600,280 |
RGD:6480464 |
CTD |
| G |
Atp6ap1l |
ATPase, H+ transporting, lysosomal accessory protein 1-like |
|
increases expression |
EXP |
2 |
21,004,512 |
21,032,007 |
RGD:6480464 |
CTD |
| G |
Atp6v1a |
ATPase, H+ transporting, lysosomal V1 subunit A |
|
increases expression |
ISO |
11 |
58,127,307 |
58,180,225 |
RGD:6480464 |
CTD |
| G |
Atp6v1b2 |
ATPase, H transporting, lysosomal V1 subunit B2 |
|
increases expression |
ISO |
16 |
22,320,425 |
22,344,445 |
RGD:6480464 |
CTD |
| G |
Atp6v1b2 |
ATPase, H transporting, lysosomal V1 subunit B2 |
|
decreases expression |
EXP |
16 |
22,320,425 |
22,344,445 |
RGD:6480464 |
CTD |
| G |
Atp6v1b2 |
ATPase, H transporting, lysosomal V1 subunit B2 |
|
multiple interactions |
EXP |
16 |
22,320,425 |
22,344,445 |
RGD:6480464 |
CTD |
| G |
Atxn3 |
ataxin 3 |
|
increases expression |
EXP |
6 |
126,196,043 |
126,229,844 |
RGD:6480464 |
CTD |
| G |
Aurka |
aurora kinase A |
|
increases expression |
ISO |
3 |
163,270,479 |
163,284,506 |
RGD:6480464 |
CTD |
| G |
B2m |
beta-2 microglobulin |
|
increases expression |
EXP |
3 |
108,927,919 |
108,932,718 |
RGD:6480464 |
CTD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
increases expression |
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:6480464 |
CTD |
| G |
Bag1 |
BCL2-associated athanogene |
|
increases expression |
EXP |
5 |
58,329,720 |
58,342,293 |
RGD:6480464 |
CTD |
| G |
Bai3 |
brain-specific angiogenesis inhibitor 3 |
|
decreases expression |
EXP |
9 |
23,759,340 |
24,495,409 |
RGD:6480464 |
CTD |
| G |
Bambi |
BMP and activin membrane-bound inhibitor, homolog (Xenopus laevis) |
|
decreases expression |
EXP |
17 |
62,654,385 |
62,658,641 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
ISO |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bax |
Bcl2-associated X protein |
|
increases expression |
EXP |
1 |
95,933,023 |
95,938,176 |
RGD:6480464 |
CTD |
| G |
Bcat1 |
branched chain amino acid transaminase 1, cytosolic |
|
increases expression |
ISO |
4 |
182,641,517 |
182,692,917 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
increases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
EXP |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2 |
B-cell CLL/lymphoma 2 |
|
decreases expression |
ISO |
13 |
12,730,736 |
12,905,108 |
RGD:6480464 |
CTD |
| G |
Bcl2l1 |
Bcl2-like 1 |
|
decreases expression |
ISO |
3 |
143,129,087 |
143,180,199 |
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
multiple interactions |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Bdnf |
brain-derived neurotrophic factor |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Bex4 |
brain expressed, X-linked 4 |
|
decreases expression |
ISO |
X |
123,442,511 |
123,443,772 |
RGD:6480464 |
CTD |
| G |
Bhlhe40 |
basic helix-loop-helix family, member e40 |
|
increases expression |
ISO |
4 |
144,139,486 |
144,145,186 |
RGD:6480464 |
CTD |
| G |
Bhmt |
betaine-homocysteine S-methyltransferase |
|
increases expression |
ISO |
2 |
23,923,651 |
23,943,320 |
RGD:6480464 |
CTD |
| G |
Bhmt |
betaine-homocysteine S-methyltransferase |
|
multiple interactions |
ISO |
2 |
23,923,651 |
23,943,320 |
RGD:6480464 |
CTD |
| G |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
|
decreases expression |
EXP |
15 |
46,516,626 |
46,539,756 |
RGD:6480464 |
CTD |
| G |
Bnip3l |
BCL2/adenovirus E1B interacting protein 3-like |
|
increases expression |
EXP |
15 |
46,516,626 |
46,539,756 |
RGD:6480464 |
CTD |
| G |
Bsg |
basigin (Ok blood group) |
|
increases expression |
ISO |
7 |
11,507,914 |
11,515,132 |
RGD:6480464 |
CTD |
| G |
Btg2 |
BTG family, member 2 |
|
increases expression |
EXP |
13 |
47,026,986 |
47,030,745 |
RGD:6480464 |
CTD |
| G |
Bub1b |
BUB1 mitotic checkpoint serine/threonine kinase B |
|
affects expression |
ISO |
3 |
105,063,018 |
105,116,145 |
RGD:6480464 |
CTD |
| G |
C1qa |
complement component 1, q subcomponent, A chain |
|
decreases expression |
ISO |
5 |
155,662,333 |
155,665,180 |
RGD:6480464 |
CTD |
| G |
C1qa |
complement component 1, q subcomponent, A chain |
|
increases expression |
ISO |
5 |
155,662,333 |
155,665,180 |
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
C3 |
complement component 3 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
increases expression |
ISO |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
decreases expression |
ISO |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Ca2 |
carbonic anhydrase 2 |
|
increases expression |
ISO |
2 |
88,077,095 |
88,092,223 |
RGD:6480464 |
CTD |
| G |
Cables1 |
Cdk5 and Abl enzyme substrate 1 |
|
increases expression |
ISO |
18 |
3,425,890 |
3,529,998 |
RGD:6480464 |
CTD |
| G |
Calb1 |
calbindin 1 |
|
decreases expression |
ISO |
5 |
30,455,665 |
30,480,122 |
RGD:6480464 |
CTD |
| G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
|
increases activity |
ISO |
18 |
56,879,247 |
56,948,537 |
RGD:6480464 |
CTD |
| G |
Camk2a |
calcium/calmodulin-dependent protein kinase II alpha |
|
multiple interactions |
ISO |
18 |
56,879,247 |
56,948,537 |
RGD:6480464 |
CTD |
| G |
Camk2b |
calcium/calmodulin-dependent protein kinase II beta |
|
increases expression |
ISO |
14 |
86,632,686 |
86,721,281 |
RGD:6480464 |
CTD |
| G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
|
increases activity |
ISO |
18 |
25,404,123 |
25,625,785 |
RGD:6480464 |
CTD |
| G |
Camk4 |
calcium/calmodulin-dependent protein kinase IV |
|
multiple interactions |
ISO |
18 |
25,404,123 |
25,625,785 |
RGD:6480464 |
CTD |
| G |
Capg |
capping protein (actin filament), gelsolin-like |
|
increases expression |
ISO |
4 |
105,850,321 |
105,862,109 |
RGD:6480464 |
CTD |
| G |
Capn5 |
calpain 5 |
|
increases expression |
ISO |
1 |
155,366,678 |
155,421,183 |
RGD:6480464 |
CTD |
| G |
Capn9 |
calpain 9 |
|
increases expression |
ISO |
19 |
54,759,009 |
54,796,390 |
RGD:6480464 |
CTD |
| G |
Capns1 |
calpain, small subunit 1 |
|
increases expression |
ISO |
1 |
85,519,568 |
85,525,929 |
RGD:6480464 |
CTD |
| G |
Casc1 |
cancer susceptibility candidate 1 |
|
decreases expression |
ISO |
4 |
182,823,026 |
182,859,566 |
RGD:6480464 |
CTD |
| G |
Casp3 |
caspase 3 |
|
increases activity |
ISO |
16 |
48,944,226 |
48,962,420 |
RGD:6480464 |
CTD |
| G |
Casp8 |
caspase 8 |
|
increases expression |
ISO |
9 |
57,389,353 |
57,437,803 |
RGD:6480464 |
CTD |
| G |
Cbfa2t3 |
core-binding factor, runt domain, alpha subunit 2; translocated to, 3 |
|
increases expression |
ISO |
19 |
52,908,942 |
52,980,399 |
RGD:6480464 |
CTD |
| G |
Ccbp2 |
chemokine binding protein 2 |
|
decreases expression |
ISO |
8 |
127,026,528 |
127,028,214 |
RGD:6480464 |
CTD |
| G |
Ccdc19 |
coiled-coil domain containing 19 |
|
decreases expression |
ISO |
13 |
88,527,708 |
88,551,091 |
RGD:6480464 |
CTD |
| G |
Ccl2 |
chemokine (C-C motif) ligand 2 |
|
increases expression |
ISO |
10 |
70,256,263 |
70,258,061 |
RGD:6480464 |
CTD |
| G |
Ccl7 |
chemokine (C-C motif) ligand 7 |
|
increases expression |
EXP |
10 |
70,267,281 |
70,269,131 |
RGD:6480464 |
CTD |
| G |
Ccnb1 |
cyclin B1 |
|
increases expression |
EXP |
2 |
31,574,600 |
31,581,784 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
decreases expression |
ISO |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccnd1 |
cyclin D1 |
|
increases expression |
EXP |
1 |
205,357,235 |
205,366,757 |
RGD:6480464 |
CTD |
| G |
Ccng1 |
cyclin G1 |
|
increases expression |
EXP |
10 |
25,776,380 |
25,782,754 |
RGD:6480464 |
CTD |
| G |
Cct3 |
chaperonin containing Tcp1, subunit 3 (gamma) |
|
increases expression |
EXP |
2 |
180,381,044 |
180,434,152 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
decreases expression |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd14 |
CD14 molecule |
|
increases expression |
ISO |
18 |
29,374,593 |
29,376,190 |
RGD:6480464 |
CTD |
| G |
Cd200 |
Cd200 molecule |
|
decreases expression |
ISO |
11 |
56,946,504 |
56,974,256 |
RGD:6480464 |
CTD |
| G |
Cd24 |
CD24 molecule |
|
increases expression |
ISO |
20 |
47,502,354 |
47,507,663 |
RGD:6480464 |
CTD |
| G |
Cd55 |
Cd55 molecule |
|
increases expression |
EXP |
13 |
43,322,246 |
43,348,334 |
RGD:6480464 |
CTD |
| G |
Cd68 |
Cd68 molecule |
|
increases expression |
ISO |
10 |
56,481,701 |
56,483,580 |
RGD:6480464 |
CTD |
| G |
Cd70 |
Cd70 molecule |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cd86 |
CD86 molecule |
|
increases expression |
ISO |
11 |
66,215,233 |
66,238,882 |
RGD:6480464 |
CTD |
| G |
Cd9 |
CD9 molecule |
|
increases expression |
ISO |
4 |
162,279,462 |
162,312,889 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
increases expression |
ISO |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc20 |
cell division cycle 20 |
|
increases expression |
EXP |
5 |
138,913,180 |
138,916,744 |
RGD:6480464 |
CTD |
| G |
Cdc25c |
cell division cycle 25C |
|
decreases expression |
ISO |
18 |
27,206,537 |
27,225,811 |
RGD:6480464 |
CTD |
| G |
Cdcp1 |
CUB domain containing protein 1 |
|
increases expression |
ISO |
8 |
127,951,811 |
127,988,666 |
RGD:6480464 |
CTD |
| G |
Cdh16 |
cadherin 16 |
|
increases expression |
ISO |
19 |
279,359 |
289,543 |
RGD:6480464 |
CTD |
| G |
Cdk1 |
cyclin-dependent kinase 1 |
|
increases expression |
EXP |
20 |
20,018,044 |
20,044,030 |
RGD:6480464 |
CTD |
| G |
Cdk10 |
cyclin-dependent kinase 10 |
|
increases expression |
ISO |
19 |
53,545,204 |
53,552,911 |
RGD:6480464 |
CTD |
| G |
Cdk16 |
cyclin-dependent kinase 16 |
|
increases expression |
EXP |
X |
12,910,972 |
12,916,939 |
RGD:6480464 |
CTD |
| G |
Cdk4 |
cyclin-dependent kinase 4 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cdk5 |
cyclin-dependent kinase 5 |
|
increases expression |
ISO |
4 |
6,119,704 |
6,124,186 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
ISO |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1a |
cyclin-dependent kinase inhibitor 1A |
|
increases expression |
EXP |
20 |
7,376,325 |
7,386,778 |
RGD:6480464 |
CTD |
| G |
Cdkn1b |
cyclin-dependent kinase inhibitor 1B |
|
increases expression |
EXP |
4 |
171,841,705 |
171,846,506 |
RGD:6480464 |
CTD |
| G |
Cdkn1c |
cyclin-dependent kinase inhibitor 1C |
|
increases expression |
ISO |
1 |
203,835,215 |
203,837,844 |
RGD:6480464 |
CTD |
| G |
Ceacam1 |
carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) |
|
increases expression |
ISO |
1 |
80,742,540 |
80,758,943 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpb |
CCAAT/enhancer binding protein (C/EBP), beta |
|
increases expression |
ISO |
3 |
158,826,021 |
158,827,848 |
RGD:6480464 |
CTD |
| G |
Cebpd |
CCAAT/enhancer binding protein (C/EBP), delta |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cfb |
complement factor B |
|
increases expression |
ISO |
20 |
4,072,124 |
4,077,802 |
RGD:6480464 |
CTD |
| G |
Cfi |
complement factor I |
|
increases expression |
ISO |
2 |
227,281,621 |
227,325,109 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
decreases activity |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Cftr |
cystic fibrosis transmembrane conductance regulator |
|
increases expression |
ISO |
4 |
43,874,852 |
44,041,870 |
RGD:6480464 |
CTD |
| G |
Cgref1 |
cell growth regulator with EF hand domain 1 |
|
increases expression |
EXP |
6 |
25,414,812 |
25,426,818 |
RGD:6480464 |
CTD |
| G |
Cgrrf1 |
cell growth regulator with ring finger domain 1 |
|
decreases expression |
EXP |
15 |
22,683,387 |
22,703,833 |
RGD:6480464 |
CTD |
| G |
Chac2 |
ChaC, cation transport regulator homolog 2 (E. coli) |
|
increases expression |
ISO |
14 |
112,082,173 |
112,122,592 |
RGD:6480464 |
CTD |
| G |
Chrna3 |
cholinergic receptor, nicotinic, alpha 3 (neuronal) |
|
multiple interactions |
ISO |
8 |
58,570,223 |
58,583,594 |
RGD:6480464 |
CTD |
| G |
Chrna4 |
cholinergic receptor, nicotinic, alpha 4 (neuronal) |
|
multiple interactions |
ISO |
3 |
170,171,214 |
170,185,998 |
RGD:6480464 |
CTD |
| G |
Chrnb2 |
cholinergic receptor, nicotinic, beta 2 (neuronal) |
|
multiple interactions |
ISO |
2 |
181,961,373 |
181,969,581 |
RGD:6480464 |
CTD |
| G |
Chrnb4 |
cholinergic receptor, nicotinic, beta 4 (neuronal) |
|
multiple interactions |
ISO |
8 |
58,586,961 |
58,605,545 |
RGD:6480464 |
CTD |
| G |
Cilp |
cartilage intermediate layer protein, nucleotide pyrophosphohydrolase |
|
increases expression |
ISO |
8 |
69,501,820 |
69,517,136 |
RGD:6480464 |
CTD |
| G |
Cited2 |
Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2 |
|
increases expression |
ISO |
1 |
12,721,500 |
12,723,943 |
RGD:6480464 |
CTD |
| G |
Ckb |
creatine kinase, brain |
|
increases expression |
ISO |
6 |
136,452,215 |
136,455,122 |
RGD:6480464 |
CTD |
| G |
Ckmt1b |
creatine kinase, mitochondrial 1B |
|
increases expression |
ISO |
3 |
108,158,887 |
108,163,888 |
RGD:6480464 |
CTD |
| G |
Cks1b |
CDC28 protein kinase regulatory subunit 1B |
|
increases expression |
ISO |
2 |
181,611,639 |
181,616,222 |
RGD:6480464 |
CTD |
| G |
Cks2 |
CDC28 protein kinase regulatory subunit 2 |
|
increases expression |
ISO |
17 |
19,423,502 |
19,429,451 |
RGD:6480464 |
CTD |
| G |
Cldn3 |
claudin 3 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cldn5 |
claudin 5 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Cldn5 |
claudin 5 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cldn7 |
claudin 7 |
|
increases expression |
ISO |
10 |
56,810,947 |
56,813,134 |
RGD:6480464 |
CTD |
| G |
Clstn2 |
calsyntenin 2 |
|
increases expression |
EXP |
8 |
102,614,117 |
103,214,037 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
increases expression |
ISO |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
increases expression |
ISO |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Clu |
clusterin |
|
decreases expression |
ISO |
15 |
45,365,779 |
45,405,314 |
RGD:6480464 |
CTD |
| G |
Cmtm3 |
CKLF-like MARVEL transmembrane domain containing 3 |
|
decreases expression |
ISO |
19 |
579,430 |
586,297 |
RGD:6480464 |
CTD |
| G |
Cndp2 |
CNDP dipeptidase 2 (metallopeptidase M20 family) |
|
increases expression |
ISO |
18 |
81,215,851 |
81,232,949 |
RGD:6480464 |
CTD |
| G |
Coch |
coagulation factor C homolog, cochlin (Limulus polyphemus) |
|
decreases expression |
ISO |
6 |
71,692,946 |
71,697,056 |
RGD:6480464 |
CTD |
| G |
Col1a1 |
collagen, type I, alpha 1 |
|
increases expression |
ISO |
10 |
83,622,438 |
83,639,368 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
increases expression |
ISO |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Col1a2 |
collagen, type I, alpha 2 |
|
increases expression |
EXP |
4 |
29,393,645 |
29,428,572 |
RGD:6480464 |
CTD |
| G |
Cp |
ceruloplasmin (ferroxidase) |
|
increases expression |
ISO |
2 |
105,086,278 |
105,135,367 |
RGD:6480464 |
CTD |
| G |
Cpm |
carboxypeptidase M |
|
increases expression |
ISO |
7 |
56,931,920 |
56,992,248 |
RGD:6480464 |
CTD |
| G |
Cpxm2 |
carboxypeptidase X (M14 family), member 2 |
|
decreases expression |
ISO |
1 |
191,510,790 |
191,624,219 |
RGD:6480464 |
CTD |
| G |
Cr1l |
complement component (3b/4b) receptor 1-like |
|
increases expression |
EXP |
13 |
111,010,296 |
111,057,427 |
RGD:6480464 |
CTD |
| G |
Crabp2 |
cellular retinoic acid binding protein 2 |
|
increases expression |
EXP |
2 |
180,029,801 |
180,034,147 |
RGD:6480464 |
CTD |
| G |
Csgalnact1 |
chondroitin sulfate N-acetylgalactosaminyltransferase 1 |
|
increases expression |
EXP |
16 |
22,852,516 |
22,947,139 |
RGD:6480464 |
CTD |
| G |
Csnk2a2 |
casein kinase 2, alpha prime polypeptide |
|
affects expression |
ISO |
19 |
10,015,369 |
10,054,662 |
RGD:6480464 |
CTD |
| G |
Cst3 |
cystatin C |
|
increases expression |
ISO |
3 |
137,650,903 |
137,654,776 |
RGD:6480464 |
CTD |
| G |
Cstb |
cystatin B (stefin B) |
|
increases expression |
ISO |
20 |
10,576,664 |
10,578,706 |
RGD:6480464 |
CTD |
| G |
Cstb |
cystatin B (stefin B) |
|
increases expression |
EXP |
20 |
10,576,664 |
10,578,706 |
RGD:6480464 |
CTD |
| G |
Ctnnb1 |
catenin (cadherin associated protein), beta 1 |
|
increases expression |
ISO |
8 |
125,978,161 |
125,987,670 |
RGD:6480464 |
CTD |
| G |
Ctnnd1 |
catenin (cadherin associated protein), delta 1 |
|
increases expression |
ISO |
3 |
67,809,603 |
67,860,287 |
RGD:6480464 |
CTD |
| G |
Ctsa |
cathepsin A |
|
increases expression |
ISO |
3 |
155,866,335 |
155,871,998 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
increases activity |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctsb |
cathepsin B |
|
increases expression |
ISO |
15 |
42,402,829 |
42,423,701 |
RGD:6480464 |
CTD |
| G |
Ctsc |
cathepsin C |
|
increases expression |
ISO |
1 |
144,629,802 |
144,661,183 |
RGD:6480464 |
CTD |
| G |
Ctsd |
cathepsin D |
|
increases expression |
EXP |
1 |
202,619,669 |
202,631,545 |
RGD:6480464 |
CTD |
| G |
Ctsh |
cathepsin H |
|
increases expression |
ISO |
8 |
94,971,689 |
94,990,434 |
RGD:6480464 |
CTD |
| G |
Ctsl1 |
cathepsin L1 |
|
increases expression |
ISO |
17 |
6,288,013 |
6,294,174 |
RGD:6480464 |
CTD |
| G |
Cttn |
cortactin |
|
decreases expression |
ISO |
1 |
204,865,768 |
204,901,221 |
RGD:6480464 |
CTD |
| G |
Cuzd1 |
CUB and zona pellucida-like domains 1 |
|
decreases expression |
ISO |
1 |
190,887,527 |
190,900,654 |
RGD:6480464 |
CTD |
| G |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
|
increases expression |
EXP |
14 |
17,265,986 |
17,268,183 |
RGD:6480464 |
CTD |
| G |
Cxcl14 |
chemokine (C-X-C motif) ligand 14 |
|
increases expression |
ISO |
17 |
14,286,747 |
14,295,502 |
RGD:6480464 |
CTD |
| G |
Cxcl5 |
chemokine (C-X-C motif) ligand 5 |
|
decreases expression |
ISO |
14 |
18,825,357 |
18,826,269 |
RGD:6480464 |
CTD |
| G |
Cyb561 |
cytochrome b-561 |
|
increases expression |
ISO |
10 |
95,328,354 |
95,334,603 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
affects localization |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
increases expression |
EXP |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cycs |
cytochrome c, somatic |
|
multiple interactions |
ISO |
4 |
78,825,878 |
78,827,978 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
increases expression |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp11a1 |
cytochrome P450, family 11, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
8 |
61,793,976 |
61,805,308 |
RGD:6480464 |
CTD |
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
affects expression |
ISO |
1 |
251,965,458 |
251,971,449 |
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
decreases expression |
ISO |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
increases expression |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
|
multiple interactions |
EXP |
8 |
61,462,207 |
61,468,237 |
RGD:6480464 |
CTD |
| G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
|
affects response to substance |
ISO |
8 |
61,439,062 |
61,447,861 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
multiple interactions |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp1b1 |
cytochrome P450, family 1, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
6 |
2,548,224 |
2,553,767 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
increases expression |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
multiple interactions |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2a3 |
cytochrome P450, family 2, subfamily a, polypeptide 3 |
|
multiple interactions |
ISO |
1 |
81,944,896 |
81,953,007 |
RGD:6480464 |
CTD |
| G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
|
increases expression |
EXP |
1 |
81,266,828 |
81,290,471 |
RGD:6480464 |
CTD |
| G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
|
increases expression |
EXP |
1 |
81,345,425 |
81,359,415 |
RGD:6480464 |
CTD |
| G |
Cyp2f4 |
cytochrome P450, family 2, subfamily f, polypeptide 4 |
|
decreases expression |
ISO |
1 |
82,191,741 |
82,204,629 |
RGD:6480464 |
CTD |
| G |
Cyp4a8 |
cytochrome P450, family 4, subfamily a, polypeptide 8 |
|
increases expression |
EXP |
5 |
135,546,858 |
135,578,199 |
RGD:6480464 |
CTD |
| G |
Dad1 |
defender against cell death 1 |
|
increases expression |
ISO |
15 |
32,285,592 |
32,305,885 |
RGD:6480464 |
CTD |
| G |
Dapl1 |
death associated protein-like 1 |
|
decreases expression |
EXP |
3 |
41,187,967 |
41,207,910 |
RGD:6480464 |
CTD |
| G |
Dcc |
deleted in colorectal carcinoma |
|
increases expression |
ISO |
18 |
68,026,795 |
69,140,741 |
RGD:6480464 |
CTD |
| G |
Dcn |
decorin |
|
decreases expression |
ISO |
7 |
35,004,234 |
35,045,191 |
RGD:6480464 |
CTD |
| G |
Dda1 |
DET1 and DDB1 associated 1 |
|
increases expression |
ISO |
16 |
18,640,020 |
18,647,613 |
RGD:6480464 |
CTD |
| G |
Ddah1 |
dimethylarginine dimethylaminohydrolase 1 |
|
increases expression |
EXP |
2 |
243,932,221 |
244,069,832 |
RGD:6480464 |
CTD |
| G |
Ddit3 |
DNA-damage inducible transcript 3 |
|
increases expression |
ISO |
7 |
67,247,749 |
67,252,571 |
RGD:6480464 |
CTD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
increases expression |
ISO |
20 |
27,252,273 |
27,254,371 |
RGD:6480464 |
CTD |
| G |
Ddr1 |
discoidin domain receptor tyrosine kinase 1 |
|
increases expression |
ISO |
20 |
3,194,265 |
3,214,611 |
RGD:6480464 |
CTD |
| G |
Ddx21b |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 21b |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Dedd |
death effector domain-containing |
|
affects expression |
ISO |
13 |
87,238,315 |
87,241,703 |
RGD:6480464 |
CTD |
| G |
Deptor |
DEP domain containing MTOR-interacting protein |
|
increases expression |
ISO |
7 |
91,675,825 |
91,742,576 |
RGD:6480464 |
CTD |
| G |
Dhrs3 |
dehydrogenase/reductase (SDR family) member 3 |
|
increases expression |
ISO |
5 |
163,341,856 |
163,375,604 |
RGD:6480464 |
CTD |
| G |
Dlg3 |
discs, large homolog 3 (Drosophila) |
|
increases expression |
EXP |
X |
88,777,585 |
88,828,504 |
RGD:6480464 |
CTD |
| G |
Dlx4 |
distal-less homeobox 4 |
|
decreases expression |
ISO |
10 |
83,822,815 |
83,828,210 |
RGD:6480464 |
CTD |
| G |
Dnah8 |
dynein, axonemal, heavy chain 8 |
|
increases expression |
ISO |
20 |
8,936,173 |
9,199,913 |
RGD:6480464 |
CTD |
| G |
Dnmt1 |
DNA (cytosine-5-)-methyltransferase 1 |
|
increases expression |
ISO |
8 |
19,926,995 |
19,973,256 |
RGD:6480464 |
CTD |
| G |
Dnmt3a |
DNA (cytosine-5-)-methyltransferase 3 alpha |
|
increases expression |
ISO |
6 |
26,802,612 |
26,878,878 |
RGD:6480464 |
CTD |
| G |
Dnmt3b |
DNA (cytosine-5-)-methyltransferase 3 beta |
|
increases expression |
ISO |
3 |
144,030,737 |
144,069,265 |
RGD:6480464 |
CTD |
| G |
Dnph1 |
2'-deoxynucleoside 5'-phosphate N-hydrolase 1 |
|
increases expression |
ISO |
9 |
9,865,096 |
9,867,833 |
RGD:6480464 |
CTD |
| G |
Dok4 |
docking protein 4 |
|
increases expression |
ISO |
19 |
10,585,647 |
10,596,322 |
RGD:6480464 |
CTD |
| G |
Dpyd |
dihydropyrimidine dehydrogenase |
|
decreases expression |
EXP |
2 |
214,931,901 |
215,818,809 |
RGD:6480464 |
CTD |
| G |
Dusp1 |
dual specificity phosphatase 1 |
|
increases expression |
EXP |
10 |
16,942,913 |
16,945,696 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
decreases expression |
EXP |
7 |
36,893,264 |
36,897,494 |
RGD:6480464 |
CTD |
| G |
Dusp6 |
dual specificity phosphatase 6 |
|
decreases expression |
ISO |
7 |
36,893,264 |
36,897,494 |
RGD:6480464 |
CTD |
| G |
Dut |
deoxyuridine triphosphatase |
|
increases expression |
EXP |
3 |
112,551,434 |
112,562,434 |
RGD:6480464 |
CTD |
| G |
Dynll1 |
dynein light chain LC8-type 1 |
|
decreases expression |
EXP |
12 |
42,580,542 |
42,582,915 |
RGD:6480464 |
CTD |
| G |
Dynll1 |
dynein light chain LC8-type 1 |
|
increases expression |
EXP |
12 |
42,580,542 |
42,582,915 |
RGD:6480464 |
CTD |
| G |
Eef1g |
eukaryotic translation elongation factor 1 gamma |
|
increases expression |
EXP |
1 |
211,640,954 |
211,651,560 |
RGD:6480464 |
CTD |
| G |
Eef2 |
eukaryotic translation elongation factor 2 |
|
increases expression |
EXP |
7 |
10,017,061 |
10,022,331 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
increases expression |
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
increases expression |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egf |
epidermal growth factor |
|
multiple interactions |
EXP |
2 |
227,103,900 |
227,195,062 |
RGD:6480464 |
CTD |
| G |
Egfr |
epidermal growth factor receptor |
|
increases expression |
EXP |
14 |
97,617,358 |
97,788,211 |
RGD:6480464 |
CTD |
| G |
Egln3 |
EGL nine homolog 3 (C. elegans) |
|
increases expression |
ISO |
6 |
74,451,038 |
74,476,506 |
RGD:6480464 |
CTD |
| G |
Egr1 |
early growth response 1 |
|
increases expression |
ISO |
18 |
27,343,919 |
27,346,117 |
RGD:6480464 |
CTD |
| G |
Egr3 |
early growth response 3 |
|
increases expression |
ISO |
15 |
50,477,453 |
50,479,909 |
RGD:6480464 |
CTD |
| G |
Ehd4 |
EH-domain containing 4 |
|
increases expression |
EXP |
3 |
106,594,931 |
106,658,722 |
RGD:6480464 |
CTD |
| G |
Ei24 |
etoposide induced 2.4 |
|
increases expression |
ISO |
8 |
38,028,043 |
38,044,316 |
RGD:6480464 |
CTD |
| G |
Eif4ebp1 |
eukaryotic translation initiation factor 4E binding protein 1 |
|
increases expression |
EXP |
16 |
69,110,522 |
69,123,895 |
RGD:6480464 |
CTD |
| G |
Elf3 |
E74-like factor 3 |
|
increases expression |
ISO |
13 |
48,258,893 |
48,263,713 |
RGD:6480464 |
CTD |
| G |
Elf3 |
E74-like factor 3 |
|
increases expression |
ISO |
13 |
48,258,893 |
48,263,713 |
RGD:6480464 |
CTD |
| G |
Elf5 |
E74-like factor 5 |
|
increases expression |
ISO |
3 |
88,691,632 |
88,720,167 |
RGD:6480464 |
CTD |
| G |
Emb |
embigin |
|
decreases expression |
ISO |
2 |
49,098,743 |
49,155,221 |
RGD:6480464 |
CTD |
| G |
Emp1 |
epithelial membrane protein 1 |
|
increases expression |
EXP |
4 |
172,315,122 |
172,335,536 |
RGD:6480464 |
CTD |
| G |
Endou |
endonuclease, poly(U)-specific |
|
increases expression |
ISO |
7 |
136,423,018 |
136,443,640 |
RGD:6480464 |
CTD |
| G |
Eno1 |
enolase 1, (alpha) |
|
increases expression |
ISO |
5 |
167,394,131 |
167,405,516 |
RGD:6480464 |
CTD |
| G |
Eno2 |
enolase 2, gamma, neuronal |
|
decreases expression |
ISO |
4 |
160,891,003 |
160,897,723 |
RGD:6480464 |
CTD |
| G |
Entpd2 |
ectonucleoside triphosphate diphosphohydrolase 2 |
|
decreases expression |
ISO |
3 |
3,564,380 |
3,569,801 |
RGD:6480464 |
CTD |
| G |
Ep300 |
E1A binding protein p300 |
|
decreases expression |
ISO |
7 |
119,938,507 |
120,008,886 |
RGD:6480464 |
CTD |
| G |
Epb41l2 |
erythrocyte membrane protein band 4.1-like 2 |
|
increases expression |
ISO |
1 |
20,343,833 |
20,519,742 |
RGD:6480464 |
CTD |
| G |
Epcam |
epithelial cell adhesion molecule |
|
increases expression |
ISO |
6 |
11,176,664 |
11,192,628 |
RGD:6480464 |
CTD |
| G |
Epdr1 |
ependymin related protein 1 (zebrafish) |
|
decreases expression |
EXP |
17 |
53,135,000 |
53,160,954 |
RGD:6480464 |
CTD |
| G |
Ephx1 |
epoxide hydrolase 1, microsomal (xenobiotic) |
|
increases expression |
EXP |
13 |
96,722,973 |
96,752,940 |
RGD:6480464 |
CTD |
| G |
Ept1 |
ethanolaminephosphotransferase 1 (CDP-ethanolamine-specific) |
|
affects response to substance |
EXP |
6 |
26,058,654 |
26,096,822 |
RGD:6480464 |
CTD |
| G |
Erbb3 |
v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) |
|
increases expression |
ISO |
7 |
1,858,057 |
1,877,353 |
RGD:6480464 |
CTD |
| G |
Ercc5 |
excision repair cross-complementing rodent repair deficiency, complementation group 5 |
|
affects expression |
ISO |
9 |
43,248,023 |
43,293,196 |
RGD:6480464 |
CTD |
| G |
Erp27 |
endoplasmic reticulum protein 27 |
|
decreases expression |
ISO |
4 |
173,948,853 |
173,966,545 |
RGD:6480464 |
CTD |
| G |
Espn |
espin |
|
increases expression |
ISO |
5 |
169,349,723 |
169,382,076 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects binding |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects binding |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases activity |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects binding |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects activity |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
decreases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects response to substance |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases response to substance |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
ISO |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects activity |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
affects binding |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases activity |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
multiple interactions |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr1 |
estrogen receptor 1 |
|
increases expression |
EXP |
1 |
35,523,680 |
35,759,891 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
affects binding |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
affects binding |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
increases activity |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
multiple interactions |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esr2 |
estrogen receptor 2 (ER beta) |
|
increases expression |
ISO |
6 |
98,691,167 |
98,775,299 |
RGD:6480464 |
CTD |
| G |
Esrra |
estrogen related receptor, alpha |
|
multiple interactions |
ISO |
1 |
209,587,681 |
209,597,677 |
RGD:6480464 |
CTD |
| G |
Esrrb |
estrogen-related receptor beta |
|
multiple interactions |
ISO |
6 |
110,589,116 |
110,635,158 |
RGD:6480464 |
CTD |
| G |
Esrrb |
estrogen-related receptor beta |
|
decreases activity |
ISO |
6 |
110,589,116 |
110,635,158 |
RGD:6480464 |
CTD |
| G |
Esrrg |
estrogen-related receptor gamma |
|
multiple interactions |
ISO |
13 |
103,794,661 |
104,405,301 |
RGD:6480464 |
CTD |
| G |
Esrrg |
estrogen-related receptor gamma |
|
multiple interactions |
ISO |
13 |
103,794,661 |
104,405,301 |
RGD:6480464 |
CTD |
| G |
Esrrg |
estrogen-related receptor gamma |
|
multiple interactions |
ISO |
13 |
103,794,661 |
104,405,301 |
RGD:6480464 |
CTD |
| G |
Esrrg |
estrogen-related receptor gamma |
|
affects binding |
ISO |
13 |
103,794,661 |
104,405,301 |
RGD:6480464 |
CTD |
| G |
Esrrg |
estrogen-related receptor gamma |
|
multiple interactions |
ISO |
13 |
103,794,661 |
104,405,301 |
RGD:6480464 |
CTD |
| G |
Esrrg |
estrogen-related receptor gamma |
|
multiple interactions |
ISO |
13 |
103,794,661 |
104,405,301 |
RGD:6480464 |
CTD |
| G |
Esrrg |
estrogen-related receptor gamma |
|
multiple interactions |
ISO |
13 |
103,794,661 |
104,405,301 |
RGD:6480464 |
CTD |
| G |
Ezr |
ezrin |
|
increases expression |
ISO |
1 |
41,178,195 |
41,221,735 |
RGD:6480464 |
CTD |
| G |
Fabp5 |
fatty acid binding protein 5, epidermal |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Fam107a |
family with sequence similarity 107, member A |
|
decreases expression |
ISO |
15 |
18,598,082 |
18,613,890 |
RGD:6480464 |
CTD |
| G |
Fam129b |
family with sequence similarity 129, member B |
|
decreases expression |
ISO |
3 |
11,862,604 |
11,912,117 |
RGD:6480464 |
CTD |
| G |
Fam162a |
family with sequence similarity 162, member A |
|
increases expression |
EXP |
11 |
66,518,103 |
66,546,302 |
RGD:6480464 |
CTD |
| G |
Fam20c |
family with sequence similarity 20, member C |
|
increases expression |
ISO |
12 |
16,340,407 |
16,399,325 |
RGD:6480464 |
CTD |
| G |
Fam3d |
family with sequence similarity 3, member D |
|
increases expression |
ISO |
15 |
18,520,414 |
18,554,410 |
RGD:6480464 |
CTD |
| G |
Fam84b |
family with sequence similarity 84, member B |
|
increases expression |
EXP |
7 |
97,686,396 |
97,688,774 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
multiple interactions |
EXP |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Fas |
Fas (TNF receptor superfamily, member 6) |
|
increases expression |
EXP |
1 |
238,259,443 |
238,274,745 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
ISO |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
increases expression |
EXP |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Faslg |
Fas ligand (TNF superfamily, member 6) |
|
multiple interactions |
EXP |
13 |
77,472,950 |
77,480,210 |
RGD:6480464 |
CTD |
| G |
Fbln2 |
fibulin 2 |
|
increases expression |
ISO |
4 |
125,380,549 |
125,441,079 |
RGD:6480464 |
CTD |
| G |
Fcgr1a |
Fc fragment of IgG, high affinity Ia, receptor (CD64) |
|
decreases expression |
ISO |
2 |
191,095,026 |
191,103,942 |
RGD:6480464 |
CTD |
| G |
Fdps |
farnesyl diphosphate synthase |
|
increases expression |
ISO |
2 |
181,138,474 |
181,177,903 |
RGD:6480464 |
CTD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
decreases expression |
EXP |
2 |
123,893,314 |
123,947,136 |
RGD:6480464 |
CTD |
| G |
Fgfbp1 |
fibroblast growth factor binding protein 1 |
|
increases expression |
ISO |
14 |
72,242,271 |
72,243,353 |
RGD:6480464 |
CTD |
| G |
Fgr |
Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog |
|
increases expression |
ISO |
5 |
152,119,455 |
152,147,057 |
RGD:6480464 |
CTD |
| G |
Fhl2 |
four and a half LIM domains 2 |
|
increases expression |
ISO |
9 |
42,319,997 |
42,349,055 |
RGD:6480464 |
CTD |
| G |
Fkbp4 |
FK506 binding protein 4 |
|
increases expression |
EXP |
4 |
165,448,027 |
165,456,481 |
RGD:6480464 |
CTD |
| G |
Flg |
filaggrin |
|
increases expression |
ISO |
2 |
186,307,359 |
186,311,549 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
increases expression |
ISO |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fmo1 |
flavin containing monooxygenase 1 |
|
decreases expression |
ISO |
13 |
78,503,770 |
78,536,359 |
RGD:6480464 |
CTD |
| G |
Fmod |
fibromodulin |
|
decreases expression |
ISO |
13 |
46,987,714 |
46,998,331 |
RGD:6480464 |
CTD |
| G |
Fn1 |
fibronectin 1 |
|
decreases expression |
EXP |
9 |
70,702,181 |
70,771,155 |
RGD:6480464 |
CTD |
| G |
Folr1 |
folate receptor 1 (adult) |
|
decreases expression |
ISO |
1 |
159,315,191 |
159,324,141 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases methylation |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
decreases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
ISO |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
multiple interactions |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fos |
FBJ osteosarcoma oncogene |
|
increases expression |
EXP |
6 |
109,559,135 |
109,562,001 |
RGD:6480464 |
CTD |
| G |
Fosl1 |
fos-like antigen 1 |
|
increases expression |
ISO |
1 |
208,090,612 |
208,099,118 |
RGD:6480464 |
CTD |
| G |
Foxd1 |
forkhead box D1 |
|
increases expression |
ISO |
2 |
28,944,067 |
28,945,665 |
RGD:6480464 |
CTD |
| G |
Foxj1 |
forkhead box J1 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Frzb |
frizzled-related protein |
|
increases expression |
ISO |
3 |
63,350,504 |
63,383,436 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
decreases expression |
ISO |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
increases expression |
ISO |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
multiple interactions |
EXP |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Fshb |
follicle stimulating hormone, beta polypeptide |
|
decreases expression |
EXP |
3 |
92,569,344 |
92,571,254 |
RGD:6480464 |
CTD |
| G |
Fshr |
follicle stimulating hormone receptor |
|
multiple interactions |
EXP |
6 |
12,925,894 |
13,161,215 |
RGD:6480464 |
CTD |
| G |
Fut2 |
fucosyltransferase 2 (secretor status included) |
|
increases expression |
ISO |
1 |
96,118,530 |
96,137,450 |
RGD:6480464 |
CTD |
| G |
Fxyd3 |
FXYD domain-containing ion transport regulator 3 |
|
increases expression |
ISO |
1 |
86,113,706 |
86,120,488 |
RGD:6480464 |
CTD |
| G |
Fxyd4 |
FXYD domain-containing ion transport regulator 4 |
|
decreases expression |
ISO |
4 |
154,233,712 |
154,237,571 |
RGD:6480464 |
CTD |
| G |
Fxyd4 |
FXYD domain-containing ion transport regulator 4 |
|
increases expression |
EXP |
4 |
154,233,712 |
154,237,571 |
RGD:6480464 |
CTD |
| G |
Fzd2 |
frizzled family receptor 2 |
|
increases expression |
ISO |
10 |
91,709,222 |
91,711,132 |
RGD:6480464 |
CTD |
| G |
Fzd5 |
frizzled family receptor 5 |
|
increases expression |
ISO |
9 |
63,386,990 |
63,388,747 |
RGD:6480464 |
CTD |
| G |
G0s2 |
G0/G1switch 2 |
|
increases expression |
ISO |
13 |
109,121,297 |
109,122,209 |
RGD:6480464 |
CTD |
| G |
Gabrp |
gamma-aminobutyric acid (GABA-A) receptor, pi |
|
increases expression |
EXP |
10 |
18,454,555 |
18,474,564 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
multiple interactions |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
decreases expression |
EXP |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gadd45a |
growth arrest and DNA-damage-inducible, alpha |
|
increases expression |
ISO |
4 |
96,649,941 |
96,652,243 |
RGD:6480464 |
CTD |
| G |
Gal |
galanin/GMAP prepropeptide |
|
increases expression |
EXP |
1 |
205,936,352 |
205,941,215 |
RGD:6480464 |
CTD |
| G |
Galnt14 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 14 (GalNAc-T14) |
|
increases expression |
EXP |
6 |
21,776,366 |
22,007,575 |
RGD:6480464 |
CTD |
| G |
Galnt4 |
UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 4 (GalNAc-T4) |
|
increases expression |
ISO |
7 |
36,684,516 |
36,687,057 |
RGD:6480464 |
CTD |
| G |
Galr2 |
galanin receptor 2 |
|
decreases expression |
ISO |
10 |
106,394,006 |
106,396,171 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
increases expression |
ISO |
16 |
80,900,159 |
80,930,929 |
RGD:6480464 |
CTD |
| G |
Gas6 |
growth arrest specific 6 |
|
increases expression |
EXP |
16 |
80,900,159 |
80,930,929 |
RGD:6480464 |
CTD |
| G |
Gbp2 |
guanylate binding protein 2, interferon-inducible |
|
increases expression |
ISO |
2 |
240,523,000 |
240,541,078 |
RGD:6480464 |
CTD |
| G |
Gch1 |
GTP cyclohydrolase 1 |
|
increases expression |
EXP |
15 |
23,023,996 |
23,139,794 |
RGD:6480464 |
CTD |
| G |
Gclc |
glutamate-cysteine ligase, catalytic subunit |
|
increases expression |
EXP |
8 |
82,724,429 |
82,762,848 |
RGD:6480464 |
CTD |
| G |
Gdf15 |
growth differentiation factor 15 |
|
increases expression |
EXP |
16 |
19,310,882 |
19,313,465 |
RGD:6480464 |
CTD |
| G |
Gdpd5 |
glycerophosphodiester phosphodiesterase domain containing 5 |
|
increases expression |
ISO |
1 |
156,703,241 |
156,794,530 |
RGD:6480464 |
CTD |
| G |
Gja1 |
gap junction protein, alpha 1 |
|
increases expression |
ISO |
20 |
35,409,815 |
35,422,262 |
RGD:6480464 |
CTD |
| G |
Gjb2 |
gap junction protein, beta 2 |
|
increases expression |
ISO |
15 |
36,153,526 |
36,159,490 |
RGD:6480464 |
CTD |
| G |
Glb1 |
galactosidase, beta 1 |
|
increases expression |
ISO |
8 |
118,791,550 |
118,864,281 |
RGD:6480464 |
CTD |
| G |
Gli1 |
GLI family zinc finger 1 |
|
decreases expression |
ISO |
7 |
67,288,291 |
67,297,461 |
RGD:6480464 |
CTD |
| G |
Glrx |
glutaredoxin (thioltransferase) |
|
increases expression |
ISO |
2 |
2,888,605 |
2,899,216 |
RGD:6480464 |
CTD |
| G |
Gmeb2 |
glucocorticoid modulatory element binding protein 2 |
|
increases expression |
EXP |
3 |
170,394,799 |
170,430,752 |
RGD:6480464 |
CTD |
| G |
Gng5 |
guanine nucleotide binding protein (G protein), gamma 5 |
|
increases expression |
ISO |
2 |
244,702,876 |
244,711,373 |
RGD:6480464 |
CTD |
| G |
Gnl3 |
guanine nucleotide binding protein-like 3 (nucleolar) |
|
increases expression |
EXP |
16 |
6,444,437 |
6,450,375 |
RGD:6480464 |
CTD |
| G |
Gnrhr |
gonadotropin releasing hormone receptor |
|
decreases expression |
EXP |
14 |
23,625,135 |
23,656,583 |
RGD:6480464 |
CTD |
| G |
Golph2 |
golgi phosphoprotein 2 |
|
increases expression |
ISO |
17 |
10,870,405 |
10,876,329 |
RGD:6480464 |
CTD |
| G |
Grpel1 |
GrpE-like 1, mitochondrial |
|
increases expression |
EXP |
14 |
79,873,191 |
79,878,998 |
RGD:6480464 |
CTD |
| G |
Gspt1 |
G1 to S phase transition 1 |
|
increases expression |
ISO |
10 |
4,249,196 |
4,283,833 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
increases expression |
EXP |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gsr |
glutathione reductase |
|
increases expression |
ISO |
16 |
62,255,562 |
62,298,458 |
RGD:6480464 |
CTD |
| G |
Gss |
glutathione synthetase |
|
increases expression |
EXP |
3 |
146,057,517 |
146,087,820 |
RGD:6480464 |
CTD |
| G |
Gsta2 |
glutathione S-transferase alpha 2 |
|
increases expression |
EXP |
8 |
83,299,249 |
83,312,958 |
RGD:6480464 |
CTD |
| G |
Gstm3 |
glutathione S-transferase mu 3 |
|
increases expression |
ISO |
2 |
203,532,363 |
203,537,135 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
decreases expression |
ISO |
1 |
253,228,547 |
253,238,531 |
RGD:6480464 |
CTD |
| G |
Gsto1 |
glutathione S-transferase omega 1 |
|
increases expression |
ISO |
1 |
253,228,547 |
253,238,531 |
RGD:6480464 |
CTD |
| G |
Gstt2 |
glutathione S-transferase, theta 2 |
|
increases expression |
ISO |
20 |
13,221,696 |
13,225,367 |
RGD:6480464 |
CTD |
| G |
Gtf2a2 |
general transcription factor IIA, 2 |
|
increases expression |
EXP |
8 |
74,447,866 |
74,456,735 |
RGD:6480464 |
CTD |
| G |
Gtf2i |
general transcription factor II I |
|
decreases expression |
ISO |
12 |
23,470,042 |
23,545,621 |
RGD:6480464 |
CTD |
| G |
Gusb |
glucuronidase, beta |
|
increases expression |
ISO |
12 |
27,744,409 |
27,757,755 |
RGD:6480464 |
CTD |
| G |
H2afx |
H2A histone family, member X |
|
increases expression |
EXP |
8 |
47,312,609 |
47,313,938 |
RGD:6480464 |
CTD |
| G |
H2afz |
H2A histone family, member Z |
|
increases expression |
EXP |
2 |
235,353,027 |
235,355,136 |
RGD:6480464 |
CTD |
| G |
H3f3b |
H3 histone, family 3B |
|
increases expression |
EXP |
10 |
106,130,320 |
106,132,544 |
RGD:6480464 |
CTD |
| G |
H3f3b |
H3 histone, family 3B |
|
decreases expression |
EXP |
10 |
106,130,320 |
106,132,544 |
RGD:6480464 |
CTD |
| G |
Hap1 |
huntingtin-associated protein 1 |
|
decreases expression |
EXP |
10 |
89,285,396 |
89,293,631 |
RGD:6480464 |
CTD |
| G |
Hapln3 |
hyaluronan and proteoglycan link protein 3 |
|
decreases expression |
ISO |
1 |
134,851,830 |
134,859,702 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
increases expression |
EXP |
3 |
114,119,316 |
114,138,107 |
RGD:6480464 |
CTD |
| G |
Hdc |
histidine decarboxylase |
|
decreases expression |
ISO |
3 |
114,119,316 |
114,138,107 |
RGD:6480464 |
CTD |
| G |
Hes2 |
hairy and enhancer of split 2 (Drosophila) |
|
increases expression |
ISO |
5 |
169,389,231 |
169,390,276 |
RGD:6480464 |
CTD |
| G |
Hint1 |
histidine triad nucleotide binding protein 1 |
|
increases expression |
ISO |
10 |
40,271,895 |
40,275,640 |
RGD:6480464 |
CTD |
| G |
Hist1h2bg |
histone cluster 1, H2bg |
|
increases expression |
EXP |
17 |
48,771,873 |
48,772,253 |
RGD:6480464 |
CTD |
| G |
Hmga1 |
high mobility group AT-hook 1 |
|
increases expression |
ISO |
20 |
5,769,052 |
5,772,269 |
RGD:6480464 |
CTD |
| G |
Hmgb2 |
high mobility group box 2 |
|
increases expression |
EXP |
16 |
36,131,304 |
36,133,878 |
RGD:6480464 |
CTD |
| G |
Hmox1 |
heme oxygenase (decycling) 1 |
|
increases expression |
EXP |
19 |
13,963,139 |
13,969,960 |
RGD:6480464 |
CTD |
| G |
Hnf1b |
HNF1 homeobox B |
|
decreases expression |
EXP |
10 |
72,081,091 |
72,187,014 |
RGD:6480464 |
CTD |
| G |
Hnf1b |
HNF1 homeobox B |
|
increases expression |
EXP |
10 |
72,081,091 |
72,187,014 |
RGD:6480464 |
CTD |
| G |
Hoxa11 |
homeobox A11 |
|
multiple interactions |
ISO |
4 |
80,542,417 |
80,546,079 |
RGD:6480464 |
CTD |
| G |
Hoxa11 |
homeobox A11 |
|
increases expression |
ISO |
4 |
80,542,417 |
80,546,079 |
RGD:6480464 |
CTD |
| G |
Hoxa11 |
homeobox A11 |
|
decreases expression |
ISO |
4 |
80,542,417 |
80,546,079 |
RGD:6480464 |
CTD |
| G |
Hoxa11 |
homeobox A11 |
|
increases expression |
ISO |
4 |
80,542,417 |
80,546,079 |
RGD:6480464 |
CTD |
| G |
Hoxa11 |
homeobox A11 |
|
multiple interactions |
ISO |
4 |
80,542,417 |
80,546,079 |
RGD:6480464 |
CTD |
| G |
Hoxa11 |
homeobox A11 |
|
multiple interactions |
ISO |
4 |
80,542,417 |
80,546,079 |
RGD:6480464 |
CTD |
| G |
Hoxa11 |
homeobox A11 |
|
multiple interactions |
ISO |
4 |
80,542,417 |
80,546,079 |
RGD:6480464 |
CTD |
| G |
Hoxa11 |
homeobox A11 |
|
decreases expression |
EXP |
4 |
80,542,417 |
80,546,079 |
RGD:6480464 |
CTD |
| G |
Hoxa7 |
homeobox A7 |
|
increases expression |
ISO |
4 |
80,515,622 |
80,517,521 |
RGD:6480464 |
CTD |
| G |
Hoxa7 |
homeobox A7 |
|
increases expression |
ISO |
4 |
80,515,622 |
80,517,521 |
RGD:6480464 |
CTD |
| G |
Hoxb6 |
homeo box B6 |
|
increases expression |
ISO |
10 |
85,030,558 |
85,033,604 |
RGD:6480464 |
CTD |
| G |
Hrsp12 |
heat-responsive protein 12 |
|
decreases expression |
ISO |
7 |
69,930,464 |
69,944,267 |
RGD:6480464 |
CTD |
| G |
Hsd11b1 |
hydroxysteroid 11-beta dehydrogenase 1 |
|
increases expression |
EXP |
13 |
109,063,491 |
109,089,468 |
RGD:6480464 |
CTD |
| G |
Hsd17b1 |
hydroxysteroid (17-beta) dehydrogenase 1 |
|
decreases expression |
ISO |
10 |
90,094,249 |
90,096,451 |
RGD:6480464 |
CTD |
| G |
Hsd17b10 |
hydroxysteroid (17-beta) dehydrogenase 10 |
|
increases expression |
EXP |
X |
41,489,343 |
41,491,788 |
RGD:6480464 |
CTD |
| G |
Hsd17b11 |
hydroxysteroid (17-beta) dehydrogenase 11 |
|
increases expression |
ISO |
14 |
6,859,573 |
6,891,511 |
RGD:6480464 |
CTD |
| G |
Hsd17b7 |
hydroxysteroid (17-beta) dehydrogenase 7 |
|
increases expression |
EXP |
13 |
85,776,077 |
85,792,977 |
RGD:6480464 |
CTD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
decreases expression |
EXP |
2 |
193,337,342 |
193,346,799 |
RGD:6480464 |
CTD |
| G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
|
decreases expression |
ISO |
2 |
193,337,342 |
193,346,799 |
RGD:6480464 |
CTD |
| G |
Hsf1 |
heat shock transcription factor 1 |
|
increases expression |
EXP |
7 |
114,524,211 |
114,551,166 |
RGD:6480464 |
CTD |
| G |
Hsp90aa1 |
heat shock protein 90, alpha (cytosolic), class A member 1 |
|
increases expression |
EXP |
6 |
135,413,616 |
135,419,147 |
RGD:6480464 |
CTD |
| G |
Hsp90b1 |
heat shock protein 90, beta, member 1 |
|
increases expression |
ISO |
7 |
23,332,986 |
23,347,525 |
RGD:6480464 |
CTD |
| G |
Hspa1a |
heat shock protein 1A |
|
increases expression |
ISO |
20 |
3,945,716 |
3,959,552 |
RGD:6480464 |
CTD |
| G |
Hspa1l |
heat shock protein 1-like |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Hspa9 |
heat shock protein 9 |
|
increases expression |
EXP |
18 |
27,419,614 |
27,437,031 |
RGD:6480464 |
CTD |
| G |
Hspb1 |
heat shock protein 1 |
|
increases expression |
EXP |
12 |
21,911,223 |
21,912,784 |
RGD:6480464 |
CTD |
| G |
Hspe1 |
heat shock protein 1 (chaperonin 10) |
|
increases expression |
EXP |
9 |
53,895,333 |
53,898,421 |
RGD:6480464 |
CTD |
| G |
Hsph1 |
heat shock 105/110 protein 1 |
|
increases expression |
EXP |
12 |
5,794,645 |
5,811,453 |
RGD:6480464 |
CTD |
| G |
Htra1 |
HtrA serine peptidase 1 |
|
increases expression |
EXP |
1 |
190,257,899 |
190,308,325 |
RGD:6480464 |
CTD |
| G |
Ide |
insulin degrading enzyme |
|
increases expression |
EXP |
1 |
241,547,869 |
241,646,052 |
RGD:6480464 |
CTD |
| G |
Ier3 |
immediate early response 3 |
|
increases expression |
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:6480464 |
CTD |
| G |
Ifih1 |
interferon induced with helicase C domain 1 |
|
decreases methylation |
ISO |
3 |
44,547,092 |
44,593,969 |
RGD:6480464 |
CTD |
| G |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
|
increases expression |
ISO |
1 |
238,609,171 |
238,611,236 |
RGD:6480464 |
CTD |
| G |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
|
increases expression |
ISO |
1 |
238,571,300 |
238,576,443 |
RGD:6480464 |
CTD |
| G |
Ifng |
interferon gamma |
|
affects expression |
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases expression |
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
increases expression |
EXP |
7 |
24,531,669 |
24,605,742 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
decreases expression |
ISO |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
multiple interactions |
ISO |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
increases phosphorylation |
ISO |
1 |
122,704,976 |
122,990,007 |
RGD:6480464 |
CTD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
multiple interactions |
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
multiple interactions |
ISO |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp1 |
insulin-like growth factor binding protein 1 |
|
increases expression |
EXP |
14 |
87,950,222 |
87,955,289 |
RGD:6480464 |
CTD |
| G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
increases expression |
ISO |
9 |
71,966,877 |
71,994,211 |
RGD:6480464 |
CTD |
| G |
Igfbp2 |
insulin-like growth factor binding protein 2 |
|
increases expression |
ISO |
9 |
71,966,877 |
71,994,211 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
decreases expression |
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
decreases expression |
EXP |
14 |
87,959,153 |
87,967,085 |
RGD:6480464 |
CTD |
| G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
|
increases expression |
EXP |
10 |
87,822,429 |
87,834,315 |
RGD:6480464 |
CTD |
| G |
Igfbp6 |
insulin-like growth factor binding protein 6 |
|
increases expression |
ISO |
7 |
140,885,388 |
140,890,028 |
RGD:6480464 |
CTD |
| G |
Igsf6 |
immunoglobulin superfamily, member 6 |
|
increases expression |
EXP |
1 |
179,911,684 |
179,922,158 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1a |
interleukin 1 alpha |
|
increases expression |
ISO |
3 |
116,913,612 |
116,924,114 |
RGD:6480464 |
CTD |
| G |
Il1r2 |
interleukin 1 receptor, type II |
|
increases expression |
ISO |
9 |
39,279,397 |
39,319,672 |
RGD:6480464 |
CTD |
| G |
Il34 |
interleukin 34 |
|
increases expression |
EXP |
19 |
40,662,723 |
40,676,634 |
RGD:6480464 |
CTD |
| G |
Il36rn |
interleukin 36 receptor antagonist |
|
increases expression |
ISO |
3 |
2,530,402 |
2,536,999 |
RGD:6480464 |
CTD |
| G |
Il4r |
interleukin 4 receptor |
|
increases expression |
ISO |
1 |
184,612,903 |
184,637,863 |
RGD:6480464 |
CTD |
| G |
Il6 |
interleukin 6 |
|
increases expression |
ISO |
4 |
456,799 |
461,376 |
RGD:6480464 |
CTD |
| G |
Inha |
inhibin alpha |
|
multiple interactions |
EXP |
9 |
74,781,223 |
74,784,124 |
RGD:6480464 |
CTD |
| G |
Inhba |
inhibin beta-A |
|
decreases expression |
ISO |
17 |
57,244,466 |
57,257,531 |
RGD:6480464 |
CTD |
| G |
Inhba |
inhibin beta-A |
|
multiple interactions |
EXP |
17 |
57,244,466 |
57,257,531 |
RGD:6480464 |
CTD |
| G |
Inhbb |
inhibin beta-B |
|
increases expression |
ISO |
13 |
32,170,987 |
32,176,689 |
RGD:6480464 |
CTD |
| G |
Inhbb |
inhibin beta-B |
|
multiple interactions |
EXP |
13 |
32,170,987 |
32,176,689 |
RGD:6480464 |
CTD |
| G |
Inhbb |
inhibin beta-B |
|
decreases expression |
ISO |
13 |
32,170,987 |
32,176,689 |
RGD:6480464 |
CTD |
| G |
Inmt |
indolethylamine N-methyltransferase |
|
increases expression |
ISO |
4 |
83,934,018 |
83,938,314 |
RGD:6480464 |
CTD |
| G |
Inmt |
indolethylamine N-methyltransferase |
|
multiple interactions |
ISO |
4 |
83,934,018 |
83,938,314 |
RGD:6480464 |
CTD |
| G |
Irf1 |
interferon regulatory factor 1 |
|
increases expression |
EXP |
10 |
39,220,600 |
39,227,602 |
RGD:6480464 |
CTD |
| G |
Irf7 |
interferon regulatory factor 7 |
|
increases expression |
ISO |
1 |
201,456,689 |
201,459,756 |
RGD:6480464 |
CTD |
| G |
Isg15 |
ISG15 ubiquitin-like modifier |
|
increases expression |
ISO |
5 |
173,034,479 |
173,035,766 |
RGD:6480464 |
CTD |
| G |
Itga6 |
integrin, alpha 6 |
|
increases expression |
EXP |
3 |
54,202,931 |
54,272,803 |
RGD:6480464 |
CTD |
| G |
Itgae |
integrin, alpha E |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Itgb7 |
integrin, beta 7 |
|
increases expression |
ISO |
7 |
140,971,310 |
140,984,091 |
RGD:6480464 |
CTD |
| G |
Itih4 |
inter-alpha-trypsin inhibitor heavy chain family, member 4 |
|
increases expression |
EXP |
16 |
6,319,608 |
6,334,782 |
RGD:6480464 |
CTD |
| G |
Itpk1 |
inositol-tetrakisphosphate 1-kinase |
|
increases expression |
ISO |
6 |
126,837,135 |
126,969,350 |
RGD:6480464 |
CTD |
| G |
Jak2 |
Janus kinase 2 |
|
increases expression |
ISO |
1 |
232,915,995 |
232,974,763 |
RGD:6480464 |
CTD |
| G |
Jak3 |
Janus kinase 3 |
|
increases expression |
ISO |
16 |
18,878,139 |
18,889,441 |
RGD:6480464 |
CTD |
| G |
Jak3 |
Janus kinase 3 |
|
increases expression |
ISO |
16 |
18,878,139 |
18,889,441 |
RGD:6480464 |
CTD |
| G |
Jun |
jun proto-oncogene |
|
decreases expression |
ISO |
5 |
115,358,166 |
115,361,259 |
RGD:6480464 |
CTD |
| G |
Kcnf1 |
potassium voltage-gated channel, subfamily F, member 1 |
|
increases expression |
ISO |
6 |
40,910,390 |
40,913,068 |
RGD:6480464 |
CTD |
| G |
Kcnj5 |
potassium inwardly-rectifying channel, subfamily J, member 5 |
|
increases expression |
ISO |
8 |
32,082,866 |
32,104,412 |
RGD:6480464 |
CTD |
| G |
Kcnk2 |
potassium channel, subfamily K, member 2 |
|
decreases expression |
EXP |
13 |
105,376,001 |
105,574,238 |
RGD:6480464 |
CTD |
| G |
Kcnn4 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4 |
|
increases expression |
ISO |
1 |
79,613,736 |
79,628,887 |
RGD:6480464 |
CTD |
| G |
Kctd12 |
potassium channel tetramerisation domain containing 12 |
|
decreases expression |
ISO |
15 |
86,986,827 |
86,987,810 |
RGD:6480464 |
CTD |
| G |
Kdr |
kinase insert domain receptor |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Kitlg |
KIT ligand |
|
decreases expression |
ISO |
7 |
37,714,157 |
37,795,722 |
RGD:6480464 |
CTD |
| G |
Klf4 |
Kruppel-like factor 4 (gut) |
|
increases expression |
ISO |
5 |
73,446,928 |
73,451,286 |
RGD:6480464 |
CTD |
| G |
Klf9 |
Kruppel-like factor 9 |
|
decreases expression |
EXP |
1 |
226,420,949 |
226,446,376 |
RGD:6480464 |
CTD |
| G |
Klf9 |
Kruppel-like factor 9 |
|
increases expression |
EXP |
1 |
226,420,949 |
226,446,376 |
RGD:6480464 |
CTD |
| G |
Klk8 |
kallikrein related-peptidase 8 |
|
increases expression |
ISO |
1 |
94,227,185 |
94,234,028 |
RGD:6480464 |
CTD |
| G |
Krt1 |
keratin 1 |
|
increases expression |
ISO |
7 |
140,540,960 |
140,546,186 |
RGD:6480464 |
CTD |
| G |
Krt10 |
keratin 10 |
|
increases expression |
ISO |
10 |
88,288,620 |
88,292,615 |
RGD:6480464 |
CTD |
| G |
Krt13 |
keratin 13 |
|
increases expression |
ISO |
10 |
89,057,240 |
89,061,150 |
RGD:6480464 |
CTD |
| G |
Krt16 |
keratin 16 |
|
increases expression |
ISO |
10 |
89,175,449 |
89,178,168 |
RGD:6480464 |
CTD |
| G |
Krt17 |
keratin 17 |
|
decreases expression |
ISO |
10 |
89,185,097 |
89,189,816 |
RGD:6480464 |
CTD |
| G |
Krt18 |
keratin 18 |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Krt19 |
keratin 19 |
|
increases expression |
ISO |
10 |
89,080,953 |
89,085,670 |
RGD:6480464 |
CTD |
| G |
Krt23 |
keratin 23 (histone deacetylase inducible) |
|
decreases expression |
ISO |
10 |
88,420,780 |
88,436,791 |
RGD:6480464 |
CTD |
| G |
Krt4 |
keratin 4 |
|
increases expression |
ISO |
7 |
140,622,632 |
140,628,079 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
decreases expression |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Krt8 |
keratin 8 |
|
increases expression |
ISO |
7 |
140,713,902 |
140,721,199 |
RGD:6480464 |
CTD |
| G |
Krt85 |
keratin 85 |
|
increases expression |
ISO |
7 |
140,261,522 |
140,267,924 |
RGD:6480464 |
CTD |
| G |
Lamb3 |
laminin, beta 3 |
|
increases expression |
ISO |
13 |
109,148,815 |
109,190,322 |
RGD:6480464 |
CTD |
| G |
Lamb3 |
laminin, beta 3 |
|
increases expression |
ISO |
13 |
109,148,815 |
109,190,322 |
RGD:6480464 |
CTD |
| G |
Lamc2 |
laminin, gamma 2 |
|
increases expression |
ISO |
13 |
68,151,074 |
68,211,117 |
RGD:6480464 |
CTD |
| G |
Lamp3 |
lysosomal-associated membrane protein 3 |
|
decreases expression |
ISO |
11 |
83,449,326 |
83,476,622 |
RGD:6480464 |
CTD |
| G |
Lcn2 |
lipocalin 2 |
|
increases expression |
ISO |
3 |
11,511,402 |
11,514,747 |
RGD:6480464 |
CTD |
| G |
Ldha |
lactate dehydrogenase A |
|
increases expression |
EXP |
1 |
97,403,077 |
97,412,547 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
ISO |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lgals3 |
lectin, galactoside-binding, soluble, 3 |
|
increases expression |
EXP |
15 |
23,327,071 |
23,339,006 |
RGD:6480464 |
CTD |
| G |
Lgals3bp |
lectin, galactoside-binding, soluble, 3 binding protein |
|
increases expression |
ISO |
10 |
108,388,185 |
108,397,523 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
decreases expression |
ISO |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
increases expression |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhb |
luteinizing hormone beta |
|
affects expression |
EXP |
1 |
95,892,999 |
95,893,988 |
RGD:6480464 |
CTD |
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
multiple interactions |
EXP |
6 |
12,613,622 |
12,651,587 |
RGD:6480464 |
CTD |
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
decreases expression |
EXP |
6 |
12,613,622 |
12,651,587 |
RGD:6480464 |
CTD |
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
increases expression |
EXP |
6 |
12,613,622 |
12,651,587 |
RGD:6480464 |
CTD |
| G |
Litaf |
lipopolysaccharide-induced TNF factor |
|
increases expression |
EXP |
10 |
4,614,177 |
4,623,903 |
RGD:6480464 |
CTD |
| G |
Lmo4 |
LIM domain only 4 |
|
decreases expression |
ISO |
2 |
242,498,074 |
242,515,160 |
RGD:6480464 |
CTD |
| G |
Lor |
loricrin |
|
increases expression |
ISO |
2 |
184,953,538 |
184,955,283 |
RGD:6480464 |
CTD |
| G |
Lrg1 |
leucine-rich alpha-2-glycoprotein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Lsp1 |
lymphocyte-specific protein 1 |
|
decreases expression |
ISO |
1 |
202,707,305 |
202,741,026 |
RGD:6480464 |
CTD |
| G |
Lsp1 |
lymphocyte-specific protein 1 |
|
increases expression |
EXP |
1 |
202,707,305 |
202,741,026 |
RGD:6480464 |
CTD |
| G |
Lsr |
lipolysis stimulated lipoprotein receptor |
|
increases expression |
ISO |
1 |
85,993,858 |
86,009,382 |
RGD:6480464 |
CTD |
| G |
Ltbp4 |
latent transforming growth factor beta binding protein 4 |
|
decreases expression |
ISO |
1 |
82,385,953 |
82,418,177 |
RGD:6480464 |
CTD |
| G |
Ltf |
lactotransferrin |
|
decreases methylation |
ISO |
8 |
115,417,764 |
115,440,609 |
RGD:6480464 |
CTD |
| G |
Ltf |
lactotransferrin |
|
multiple interactions |
ISO |
8 |
115,417,764 |
115,440,609 |
RGD:6480464 |
CTD |
| G |
Ltf |
lactotransferrin |
|
decreases expression |
ISO |
8 |
115,417,764 |
115,440,609 |
RGD:6480464 |
CTD |
| G |
Ltf |
lactotransferrin |
|
increases expression |
ISO |
8 |
115,417,764 |
115,440,609 |
RGD:6480464 |
CTD |
| G |
Ltf |
lactotransferrin |
|
increases expression |
ISO |
8 |
115,417,764 |
115,440,609 |
RGD:6480464 |
CTD |
| G |
Ly6e |
lymphocyte antigen 6 complex, locus E |
|
increases expression |
ISO |
7 |
113,151,828 |
113,155,521 |
RGD:6480464 |
CTD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
increases expression |
ISO |
5 |
16,933,111 |
17,054,564 |
RGD:6480464 |
CTD |
| G |
Mad2l1 |
MAD2 mitotic arrest deficient-like 1 (yeast) |
|
increases expression |
ISO |
4 |
96,380,039 |
96,386,042 |
RGD:6480464 |
CTD |
| G |
Mafb |
v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian) |
|
increases expression |
ISO |
3 |
151,116,831 |
151,118,751 |
RGD:6480464 |
CTD |
| G |
Man2b1 |
mannosidase, alpha, class 2B, member 1 |
|
increases expression |
ISO |
19 |
24,711,378 |
24,730,659 |
RGD:6480464 |
CTD |
| G |
Maoa |
monoamine oxidase A |
|
increases expression |
ISO |
X |
17,678,960 |
17,745,908 |
RGD:6480464 |
CTD |
| G |
Maoa |
monoamine oxidase A |
|
decreases expression |
ISO |
X |
17,678,960 |
17,745,908 |
RGD:6480464 |
CTD |
| G |
Maob |
monoamine oxidase B |
|
decreases expression |
ISO |
X |
17,553,529 |
17,657,852 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
increases expression |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map2k1 |
mitogen activated protein kinase kinase 1 |
|
increases expression |
ISO |
8 |
68,379,074 |
68,451,554 |
RGD:6480464 |
CTD |
| G |
Map3k12 |
mitogen activated protein kinase kinase kinase 12 |
|
increases expression |
EXP |
7 |
141,254,451 |
141,264,979 |
RGD:6480464 |
CTD |
| G |
Map4k1 |
mitogen activated protein kinase kinase kinase kinase 1 |
|
decreases expression |
ISO |
1 |
84,094,589 |
84,116,015 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
multiple interactions |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk1 |
mitogen activated protein kinase 1 |
|
increases phosphorylation |
EXP |
11 |
85,968,732 |
86,030,387 |
RGD:6480464 |
CTD |
| G |
Mapk3 |
mitogen activated protein kinase 3 |
|
multiple interactions |
EXP |
1 |
185,935,044 |
185,941,245 |
RGD:6480464 |
CTD |
| G |
Mapk8 |
mitogen-activated protein kinase 8 |
|
multiple interactions |
ISO |
16 |
8,925,133 |
9,004,897 |
RGD:6480464 |
CTD |
| G |
Mapre1 |
microtubule-associated protein, RP/EB family, member 1 |
|
increases expression |
ISO |
3 |
144,120,532 |
144,148,856 |
RGD:6480464 |
CTD |
| G |
Mapt |
microtubule-associated protein tau |
|
decreases expression |
EXP |
10 |
93,411,098 |
93,508,762 |
RGD:6480464 |
CTD |
| G |
Marcks |
myristoylated alanine rich protein kinase C substrate |
|
increases expression |
EXP |
20 |
41,304,058 |
41,310,104 |
RGD:6480464 |
CTD |
| G |
Mcm6 |
minichromosome maintenance complex component 6 |
|
increases expression |
EXP |
13 |
41,045,677 |
41,070,868 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
affects mutagenesis |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
ISO |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mdm2 |
p53 E3 ubiquitin protein ligase |
|
increases expression |
EXP |
7 |
56,996,694 |
57,020,926 |
RGD:6480464 |
CTD |
| G |
Mecr |
mitochondrial trans-2-enoyl-CoA reductase |
|
increases expression |
EXP |
5 |
150,700,130 |
150,725,219 |
RGD:6480464 |
CTD |
| G |
Med24 |
mediator complex subunit 24 |
|
decreases expression |
ISO |
10 |
87,477,371 |
87,502,682 |
RGD:6480464 |
CTD |
| G |
Mef2d |
myocyte enhancer factor 2D |
|
increases expression |
EXP |
2 |
180,221,078 |
180,246,917 |
RGD:6480464 |
CTD |
| G |
Meox1 |
mesenchyme homeobox 1 |
|
decreases expression |
ISO |
10 |
90,921,589 |
90,942,298 |
RGD:6480464 |
CTD |
| G |
Meox2 |
mesenchyme homeobox 2 |
|
decreases expression |
ISO |
6 |
55,895,760 |
55,957,066 |
RGD:6480464 |
CTD |
| G |
Mfge8 |
milk fat globule-EGF factor 8 protein |
|
decreases expression |
ISO |
1 |
134,870,029 |
134,885,431 |
RGD:6480464 |
CTD |
| G |
Mfge8 |
milk fat globule-EGF factor 8 protein |
|
decreases expression |
ISO |
1 |
134,870,029 |
134,885,431 |
RGD:6480464 |
CTD |
| G |
Mgmt |
O-6-methylguanine-DNA methyltransferase |
|
increases expression |
EXP |
1 |
196,629,366 |
196,866,937 |
RGD:6480464 |
CTD |
| G |
Mgp |
matrix Gla protein |
|
increases expression |
ISO |
4 |
173,910,595 |
173,913,917 |
RGD:6480464 |
CTD |
| G |
Mgst3 |
microsomal glutathione S-transferase 3 |
|
increases expression |
ISO |
13 |
83,038,049 |
83,058,802 |
RGD:6480464 |
CTD |
| G |
Mki67 |
antigen identified by monoclonal antibody Ki-67 |
|
increases expression |
ISO |
1 |
195,310,027 |
195,336,224 |
RGD:6480464 |
CTD |
| G |
Mknk2 |
MAP kinase-interacting serine/threonine kinase 2 |
|
increases expression |
ISO |
7 |
10,550,040 |
10,561,100 |
RGD:6480464 |
CTD |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
increases expression |
ISO |
8 |
115,616,396 |
115,653,471 |
RGD:6480464 |
CTD |
| G |
Mlh1 |
mutL homolog 1, colon cancer, nonpolyposis type 2 (E. coli) |
|
affects response to substance |
ISO |
8 |
115,616,396 |
115,653,471 |
RGD:6480464 |
CTD |
| G |
Mlph |
melanophilin |
|
increases expression |
ISO |
9 |
90,113,308 |
90,149,114 |
RGD:6480464 |
CTD |
| G |
Mmp11 |
matrix metallopeptidase 11 |
|
increases expression |
ISO |
20 |
13,129,667 |
13,138,449 |
RGD:6480464 |
CTD |
| G |
Mmp7 |
matrix metallopeptidase 7 |
|
increases expression |
ISO |
8 |
4,526,018 |
4,533,730 |
RGD:6480464 |
CTD |
| G |
Mob3c |
MOB kinase activator 3C |
|
decreases methylation |
ISO |
5 |
136,088,611 |
136,095,078 |
RGD:6480464 |
CTD |
| G |
Msmb |
microseminoprotein, beta |
|
increases expression |
EXP |
16 |
7,619,432 |
7,640,019 |
RGD:6480464 |
CTD |
| G |
Msmb |
microseminoprotein, beta |
|
increases expression |
ISO |
16 |
7,619,432 |
7,640,019 |
RGD:6480464 |
CTD |
| G |
Msx2 |
msh homeobox 2 |
|
decreases expression |
ISO |
17 |
17,243,262 |
17,248,927 |
RGD:6480464 |
CTD |
| G |
Msx2 |
msh homeobox 2 |
|
decreases response to substance |
ISO |
17 |
17,243,262 |
17,248,927 |
RGD:6480464 |
CTD |
| G |
Msx2 |
msh homeobox 2 |
|
affects response to substance |
ISO |
17 |
17,243,262 |
17,248,927 |
RGD:6480464 |
CTD |
| G |
Msx2 |
msh homeobox 2 |
|
increases expression |
ISO |
17 |
17,243,262 |
17,248,927 |
RGD:6480464 |
CTD |
| G |
Mt1a |
metallothionein 1a |
|
increases expression |
EXP |
19 |
11,261,631 |
11,262,647 |
RGD:6480464 |
CTD |
| G |
Mt2A |
metallothionein 2A |
|
increases expression |
EXP |
19 |
11,267,811 |
11,268,585 |
RGD:6480464 |
CTD |
| G |
Mt3 |
metallothionein 3 |
|
increases expression |
EXP |
19 |
11,284,554 |
11,286,402 |
RGD:6480464 |
CTD |
| G |
Muc1 |
mucin 1, cell surface associated |
|
increases expression |
ISO |
2 |
181,399,482 |
181,403,640 |
RGD:6480464 |
CTD |
| G |
Muc4 |
mucin 4, cell surface associated |
|
increases expression |
EXP |
11 |
69,830,276 |
69,858,366 |
RGD:6480464 |
CTD |
| G |
Mxd1 |
max dimerization protein 1 |
|
increases expression |
ISO |
4 |
120,801,932 |
120,822,346 |
RGD:6480464 |
CTD |
| G |
Mxd4 |
Max dimerization protein 4 |
|
decreases expression |
ISO |
14 |
82,253,309 |
82,264,705 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
ISO |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
decreases expression |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
increases expression |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myc |
myelocytomatosis oncogene |
|
multiple interactions |
EXP |
7 |
98,953,142 |
98,958,060 |
RGD:6480464 |
CTD |
| G |
Myh10 |
myosin, heavy chain 10, non-muscle |
|
multiple interactions |
ISO |
10 |
55,445,288 |
55,576,096 |
RGD:6480464 |
CTD |
| G |
Myh14 |
myosin, heavy chain 14, non-muscle |
|
increases expression |
ISO |
1 |
95,081,948 |
95,146,449 |
RGD:6480464 |
CTD |
| G |
Myo1d |
myosin ID |
|
increases expression |
ISO |
10 |
68,720,729 |
68,997,721 |
RGD:6480464 |
CTD |
| G |
Nalcn |
sodium leak channel, non-selective |
|
decreases expression |
EXP |
15 |
108,414,286 |
108,658,195 |
RGD:6480464 |
CTD |
| G |
Nap1l1 |
nucleosome assembly protein 1-like 1 |
|
increases expression |
EXP |
7 |
50,506,870 |
50,530,177 |
RGD:6480464 |
CTD |
| G |
Ncald |
neurocalcin delta |
|
increases expression |
EXP |
7 |
72,875,314 |
72,976,373 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
multiple interactions |
ISO |
6 |
27,224,396 |
27,473,926 |
RGD:6480464 |
CTD |
| G |
Ncoa1 |
nuclear receptor coactivator 1 |
|
multiple interactions |
ISO |
6 |
27,224,396 |
27,473,926 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
affects binding |
ISO |
5 |
5,197,891 |
5,275,776 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
multiple interactions |
ISO |
5 |
5,197,891 |
5,275,776 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
multiple interactions |
ISO |
5 |
5,197,891 |
5,275,776 |
RGD:6480464 |
CTD |
| G |
Ncoa2 |
nuclear receptor coactivator 2 |
|
decreases expression |
ISO |
5 |
5,197,891 |
5,275,776 |
RGD:6480464 |
CTD |
| G |
Ndn |
necdin, melanoma antigen (MAGE) family member |
|
decreases expression |
EXP |
1 |
116,594,603 |
116,596,202 |
RGD:6480464 |
CTD |
| G |
Nedd4l |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
|
decreases expression |
ISO |
18 |
61,134,242 |
61,477,040 |
RGD:6480464 |
CTD |
| G |
Nell2 |
NEL-like 2 (chicken) |
|
decreases expression |
EXP |
7 |
133,758,271 |
134,080,104 |
RGD:6480464 |
CTD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
increases expression |
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:6480464 |
CTD |
| G |
Nfkbiz |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta |
|
increases expression |
ISO |
11 |
45,776,027 |
45,811,515 |
RGD:6480464 |
CTD |
| G |
Ngef |
neuronal guanine nucleotide exchange factor |
|
decreases expression |
ISO |
9 |
86,294,206 |
86,327,765 |
RGD:6480464 |
CTD |
| G |
Nid2 |
nidogen 2 (osteonidogen) |
|
increases expression |
ISO |
15 |
4,801,183 |
4,856,895 |
RGD:6480464 |
CTD |
| G |
Ninj1 |
ninjurin 1 |
|
increases expression |
EXP |
17 |
21,410,701 |
21,419,472 |
RGD:6480464 |
CTD |
| G |
Nme1 |
NME/NM23 nucleoside diphosphate kinase 1 |
|
increases expression |
ISO |
10 |
82,591,705 |
82,601,075 |
RGD:6480464 |
CTD |
| G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
increases expression |
ISO |
10 |
82,582,766 |
82,588,269 |
RGD:6480464 |
CTD |
| G |
Npm1 |
nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
|
increases expression |
EXP |
10 |
18,051,990 |
18,062,714 |
RGD:6480464 |
CTD |
| G |
Nppa |
natriuretic peptide A |
|
increases expression |
EXP |
5 |
165,074,518 |
165,075,827 |
RGD:6480464 |
CTD |
| G |
Nqo1 |
NAD(P)H dehydrogenase, quinone 1 |
|
increases expression |
EXP |
19 |
37,251,147 |
37,266,040 |
RGD:6480464 |
CTD |
| G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
|
multiple interactions |
ISO |
11 |
64,239,918 |
64,276,702 |
RGD:6480464 |
CTD |
| G |
Nr2f6 |
nuclear receptor subfamily 2, group F, member 6 |
|
increases expression |
EXP |
16 |
18,535,181 |
18,542,627 |
RGD:6480464 |
CTD |
| G |
Nrg1 |
neuregulin 1 |
|
increases expression |
EXP |
16 |
63,937,796 |
64,126,183 |
RGD:6480464 |
CTD |
| G |
Nrip1 |
nuclear receptor interacting protein 1 |
|
increases expression |
ISO |
11 |
15,066,443 |
15,150,137 |
RGD:6480464 |
CTD |
| G |
Nrp1 |
neuropilin 1 |
|
increases expression |
ISO |
19 |
58,332,004 |
58,487,686 |
RGD:6480464 |
CTD |
| G |
Nrtn |
neurturin |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Nucks1 |
nuclear casein kinase and cyclin-dependent kinase substrate 1 |
|
increases expression |
ISO |
6 |
142,904,062 |
142,905,783 |
RGD:6480464 |
CTD |
| G |
Nupr1 |
nuclear protein, transcriptional regulator, 1 |
|
increases expression |
EXP |
1 |
185,770,310 |
185,772,313 |
RGD:6480464 |
CTD |
| G |
Obp3 |
alpha-2u globulin PGCL4 |
|
decreases expression |
EXP |
5 |
78,088,876 |
78,092,317 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
affects activity |
EXP |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Odc1 |
ornithine decarboxylase 1 |
|
increases expression |
EXP |
6 |
41,309,211 |
41,315,796 |
RGD:6480464 |
CTD |
| G |
Olfm1 |
olfactomedin 1 |
|
increases expression |
ISO |
3 |
7,170,421 |
7,195,345 |
RGD:6480464 |
CTD |
| G |
Olfml3 |
olfactomedin-like 3 |
|
increases expression |
ISO |
2 |
198,958,480 |
198,961,309 |
RGD:6480464 |
CTD |
| G |
Oxt |
oxytocin/neurophysin 1 prepropeptide |
|
increases expression |
EXP |
3 |
118,194,219 |
118,195,056 |
RGD:6480464 |
CTD |
| G |
Padi1 |
peptidyl arginine deiminase, type I |
|
increases expression |
ISO |
5 |
159,671,725 |
159,704,188 |
RGD:6480464 |
CTD |
| G |
Padi2 |
peptidyl arginine deiminase, type II |
|
increases expression |
ISO |
5 |
159,762,824 |
159,805,399 |
RGD:6480464 |
CTD |
| G |
Pafah1b3 |
platelet-activating factor acetylhydrolase 1b, catalytic subunit 3 |
|
increases expression |
ISO |
1 |
80,570,160 |
80,572,686 |
RGD:6480464 |
CTD |
| G |
Papss2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
|
increases expression |
EXP |
1 |
236,592,414 |
236,677,379 |
RGD:6480464 |
CTD |
| G |
Pccb |
propionyl CoA carboxylase, beta polypeptide |
|
increases expression |
ISO |
8 |
105,946,482 |
105,996,472 |
RGD:6480464 |
CTD |
| G |
Pcdh9 |
protocadherin 9 |
|
increases expression |
EXP |
15 |
75,827,180 |
76,739,147 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
decreases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
ISO |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
decreases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
multiple interactions |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcna |
proliferating cell nuclear antigen |
|
increases expression |
EXP |
3 |
120,008,715 |
120,012,589 |
RGD:6480464 |
CTD |
| G |
Pcsk6 |
proprotein convertase subtilisin/kexin type 6 |
|
increases expression |
EXP |
1 |
120,324,843 |
120,476,913 |
RGD:6480464 |
CTD |
| G |
Pdcd6 |
programmed cell death 6 |
|
increases expression |
ISO |
1 |
29,769,911 |
29,785,577 |
RGD:6480464 |
CTD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
decreases expression |
ISO |
12 |
16,151,045 |
16,172,412 |
RGD:6480464 |
CTD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
increases expression |
EXP |
14 |
35,369,422 |
35,418,126 |
RGD:6480464 |
CTD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
increases expression |
EXP |
18 |
57,014,475 |
57,053,581 |
RGD:6480464 |
CTD |
| G |
Pdgfrl |
platelet-derived growth factor receptor-like |
|
increases expression |
EXP |
16 |
54,664,213 |
54,742,494 |
RGD:6480464 |
CTD |
| G |
Pdia4 |
protein disulfide isomerase family A, member 4 |
|
increases expression |
EXP |
4 |
75,929,398 |
75,948,299 |
RGD:6480464 |
CTD |
| G |
Pdzk1 |
PDZ domain containing 1 |
|
increases expression |
ISO |
2 |
191,643,593 |
191,675,995 |
RGD:6480464 |
CTD |
| G |
Pepd |
peptidase D |
|
increases expression |
ISO |
1 |
87,421,576 |
87,547,908 |
RGD:6480464 |
CTD |
| G |
Pfkm |
phosphofructokinase, muscle |
|
decreases expression |
EXP |
7 |
136,826,122 |
136,846,040 |
RGD:6480464 |
CTD |
| G |
Pfkm |
phosphofructokinase, muscle |
|
increases expression |
EXP |
7 |
136,826,122 |
136,846,040 |
RGD:6480464 |
CTD |
| G |
Pglyrp1 |
peptidoglycan recognition protein 1 |
|
decreases expression |
ISO |
1 |
78,235,474 |
78,240,665 |
RGD:6480464 |
CTD |
| G |
Pglyrp1 |
peptidoglycan recognition protein 1 |
|
increases expression |
ISO |
1 |
78,235,474 |
78,240,665 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
EXP |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
ISO |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
multiple interactions |
EXP |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Pgr |
progesterone receptor |
|
increases expression |
EXP |
8 |
5,784,717 |
5,845,901 |
RGD:6480464 |
CTD |
| G |
Phgdh |
phosphoglycerate dehydrogenase |
|
increases expression |
EXP |
2 |
193,147,943 |
193,177,137 |
RGD:6480464 |
CTD |
| G |
Phgdh |
phosphoglycerate dehydrogenase |
|
increases expression |
ISO |
2 |
193,147,943 |
193,177,137 |
RGD:6480464 |
CTD |
| G |
Pigr |
polymeric immunoglobulin receptor |
|
decreases expression |
ISO |
13 |
43,785,845 |
43,819,331 |
RGD:6480464 |
CTD |
| G |
Pigr |
polymeric immunoglobulin receptor |
|
increases expression |
ISO |
13 |
43,785,845 |
43,819,331 |
RGD:6480464 |
CTD |
| G |
Pik3ip1 |
phosphoinositide-3-kinase interacting protein 1 |
|
decreases expression |
ISO |
14 |
83,955,895 |
83,967,828 |
RGD:6480464 |
CTD |
| G |
Pim1 |
pim-1 oncogene |
|
increases expression |
ISO |
20 |
7,817,403 |
7,821,800 |
RGD:6480464 |
CTD |
| G |
Pkdcc |
protein kinase domain containing, cytoplasmic |
|
increases expression |
ISO |
6 |
6,554,313 |
6,563,630 |
RGD:6480464 |
CTD |
| G |
Pkp2 |
plakophilin 2 |
|
increases expression |
ISO |
11 |
86,553,493 |
86,584,425 |
RGD:6480464 |
CTD |
| G |
Plcb1 |
phospholipase C, beta 1 (phosphoinositide-specific) |
|
increases expression |
ISO |
3 |
122,797,718 |
123,523,675 |
RGD:6480464 |
CTD |
| G |
Pld3 |
phospholipase D family, member 3 |
|
increases expression |
ISO |
1 |
82,612,833 |
82,624,575 |
RGD:6480464 |
CTD |
| G |
Plod1 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 1 |
|
increases expression |
EXP |
5 |
164,987,252 |
165,012,581 |
RGD:6480464 |
CTD |
| G |
Plxdc2 |
plexin domain containing 2 |
|
increases expression |
ISO |
17 |
90,572,391 |
90,982,074 |
RGD:6480464 |
CTD |
| G |
Pold1 |
polymerase (DNA directed), delta 1, catalytic subunit |
|
multiple interactions |
EXP |
1 |
95,010,719 |
95,021,686 |
RGD:6480464 |
CTD |
| G |
Pou1f1 |
POU class 1 homeobox 1 |
|
increases expression |
ISO |
11 |
2,959,383 |
2,980,545 |
RGD:6480464 |
CTD |
| G |
Ppp2r2b |
protein phosphatase 2, regulatory subunit B, beta |
|
decreases expression |
EXP |
18 |
35,865,837 |
36,318,308 |
RGD:6480464 |
CTD |
| G |
Preb |
prolactin regulatory element binding |
|
decreases expression |
EXP |
6 |
25,401,759 |
25,405,561 |
RGD:6480464 |
CTD |
| G |
Preb |
prolactin regulatory element binding |
|
increases expression |
EXP |
6 |
25,401,759 |
25,405,561 |
RGD:6480464 |
CTD |
| G |
Prkca |
protein kinase C, alpha |
|
decreases expression |
ISO |
10 |
97,367,196 |
97,638,910 |
RGD:6480464 |
CTD |
| G |
Prkcb |
protein kinase C, beta |
|
increases expression |
ISO |
1 |
181,117,512 |
181,459,856 |
RGD:6480464 |
CTD |
| G |
Prkcb |
protein kinase C, beta |
|
increases expression |
EXP |
1 |
181,117,512 |
181,459,856 |
RGD:6480464 |
CTD |
| G |
Prkcsh |
protein kinase C substrate 80K-H |
|
increases expression |
ISO |
8 |
21,107,041 |
21,144,270 |
RGD:6480464 |
CTD |
| G |
Prkcsh |
protein kinase C substrate 80K-H |
|
increases expression |
ISO |
8 |
21,107,041 |
21,144,270 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases secretion |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
ISO |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases expression |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
increases secretion |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl |
prolactin |
|
multiple interactions |
EXP |
17 |
44,699,101 |
44,709,162 |
RGD:6480464 |
CTD |
| G |
Prl2c1 |
Prolactin family 2, subfamily c, member 1 |
|
increases expression |
ISO |
17 |
43,420,887 |
43,429,208 |
RGD:6480464 |
CTD |
| G |
Prlh |
prolactin releasing hormone |
|
multiple interactions |
EXP |
9 |
90,154,031 |
90,154,933 |
RGD:6480464 |
CTD |
| G |
Prodh |
proline dehydrogenase (oxidase) 1 |
|
decreases expression |
ISO |
11 |
84,905,060 |
84,922,229 |
RGD:6480464 |
CTD |
| G |
Prom1 |
prominin 1 |
|
increases expression |
ISO |
14 |
72,122,986 |
72,230,453 |
RGD:6480464 |
CTD |
| G |
Prom1 |
prominin 1 |
|
decreases expression |
ISO |
14 |
72,122,986 |
72,230,453 |
RGD:6480464 |
CTD |
| G |
Prr5l |
proline rich 5 like |
|
increases expression |
ISO |
3 |
86,868,129 |
86,948,468 |
RGD:6480464 |
CTD |
| G |
Psma1 |
proteasome (prosome, macropain) subunit, alpha type 1 |
|
increases expression |
EXP |
1 |
172,237,763 |
172,248,782 |
RGD:6480464 |
CTD |
| G |
Psma2 |
proteasome (prosome, macropain) subunit, alpha type 2 |
|
increases expression |
EXP |
17 |
58,736,300 |
58,746,837 |
RGD:6480464 |
CTD |
| G |
Psma4 |
proteasome (prosome, macropain) subunit, alpha type 4 |
|
increases expression |
EXP |
8 |
58,508,643 |
58,516,103 |
RGD:6480464 |
CTD |
| G |
Psma5 |
proteasome (prosome, macropain) subunit, alpha type 5 |
|
increases expression |
EXP |
2 |
203,825,060 |
203,848,378 |
RGD:6480464 |
CTD |
| G |
Psma7 |
proteasome (prosome, macropain) subunit, alpha type 7 |
|
increases expression |
EXP |
3 |
169,100,807 |
169,107,149 |
RGD:6480464 |
CTD |
| G |
Psmb1 |
proteasome (prosome, macropain) subunit, beta type 1 |
|
increases expression |
EXP |
1 |
54,369,775 |
54,388,816 |
RGD:6480464 |
CTD |
| G |
Psmb10 |
proteasome (prosome, macropain) subunit, beta type 10 |
|
increases expression |
ISO |
19 |
35,777,710 |
35,780,194 |
RGD:6480464 |
CTD |
| G |
Psmb3 |
proteasome (prosome, macropain) subunit, beta type 3 |
|
increases expression |
EXP |
10 |
86,452,533 |
86,459,616 |
RGD:6480464 |
CTD |
| G |
Psmb4 |
proteasome (prosome, macropain) subunit, beta type 4 |
|
increases expression |
EXP |
2 |
189,778,476 |
189,781,169 |
RGD:6480464 |
CTD |
| G |
Psmb5 |
proteasome (prosome, macropain) subunit, beta type 5 |
|
increases expression |
EXP |
15 |
32,689,859 |
32,694,364 |
RGD:6480464 |
CTD |
| G |
Psmb8 |
proteasome (prosome, macropain) subunit, beta type, 8 |
|
increases expression |
ISO |
20 |
4,786,260 |
4,789,223 |
RGD:6480464 |
CTD |
| G |
Psmc1 |
proteasome (prosome, macropain) 26S subunit, ATPase, 1 |
|
increases expression |
EXP |
6 |
124,380,976 |
124,393,338 |
RGD:6480464 |
CTD |
| G |
Psmc2 |
proteasome (prosome, macropain) 26S subunit, ATPase 2 |
|
increases expression |
EXP |
4 |
8,704,100 |
8,718,351 |
RGD:6480464 |
CTD |
| G |
Psmc4 |
proteasome (prosome, macropain) 26S subunit, ATPase, 4 |
|
increases expression |
EXP |
1 |
83,151,149 |
83,159,464 |
RGD:6480464 |
CTD |
| G |
Psmc5 |
proteasome (prosome, macropain) 26S subunit, ATPase, 5 |
|
increases expression |
EXP |
10 |
95,650,987 |
95,656,921 |
RGD:6480464 |
CTD |
| G |
Psmd1 |
proteasome (prosome, macropain) 26S subunit, non-ATPase, 1 |
|
increases expression |
EXP |
9 |
84,807,822 |
84,882,942 |
RGD:6480464 |
CTD |
| G |
Pten |
phosphatase and tensin homolog |
|
decreases expression |
ISO |
1 |
236,771,027 |
236,837,261 |
RGD:6480464 |
CTD |
| G |
Ptma |
prothymosin alpha |
|
increases expression |
ISO |
9 |
85,291,203 |
85,295,242 |
RGD:6480464 |
CTD |
| G |
Ptn |
pleiotrophin |
|
decreases expression |
ISO |
4 |
64,078,755 |
64,160,135 |
RGD:6480464 |
CTD |
| G |
Ptp4a1 |
protein tyrosine phosphatase type IVA, member 1 |
|
increases expression |
EXP |
9 |
29,617,636 |
29,625,197 |
RGD:6480464 |
CTD |
| G |
Ptprg |
protein tyrosine phosphatase, receptor type, G |
|
increases expression |
EXP |
15 |
14,449,352 |
15,130,760 |
RGD:6480464 |
CTD |
| G |
Pttg1 |
pituitary tumor-transforming 1 |
|
increases expression |
EXP |
10 |
28,527,409 |
28,532,831 |
RGD:6480464 |
CTD |
| G |
Pvalb |
parvalbumin |
|
decreases expression |
EXP |
7 |
116,115,034 |
116,127,508 |
RGD:6480464 |
CTD |
| G |
Qsox1 |
quiescin Q6 sulfhydryl oxidase 1 |
|
increases expression |
ISO |
13 |
70,739,793 |
70,777,526 |
RGD:6480464 |
CTD |
| G |
Rab20 |
RAB20, member RAS oncogene family |
|
decreases expression |
ISO |
16 |
82,871,002 |
82,895,146 |
RGD:6480464 |
CTD |
| G |
Rab38 |
RAB38, member RAS oncogene family |
|
decreases expression |
EXP |
1 |
144,783,919 |
144,864,573 |
RGD:6480464 |
CTD |
| G |
Rab4a |
RAB4A, member RAS oncogene family |
|
decreases expression |
ISO |
19 |
53,991,122 |
54,019,248 |
RGD:6480464 |
CTD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
increases expression |
EXP |
12 |
11,380,314 |
11,400,531 |
RGD:6480464 |
CTD |
| G |
Rap1gap |
Rap1 GTPase-activating protein |
|
increases expression |
ISO |
5 |
156,468,558 |
156,489,592 |
RGD:6480464 |
CTD |
| G |
Rasa4 |
RAS p21 protein activator 4 |
|
increases expression |
ISO |
12 |
21,668,173 |
21,695,505 |
RGD:6480464 |
CTD |
| G |
Rasal1 |
RAS protein activator like 1 (GAP1 like) |
|
decreases expression |
ISO |
12 |
37,047,909 |
37,080,129 |
RGD:6480464 |
CTD |
| G |
Rassf4 |
Ras association (RalGDS/AF-6) domain family member 4 |
|
increases expression |
EXP |
4 |
152,987,396 |
153,021,524 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
decreases expression |
EXP |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rb1 |
retinoblastoma 1 |
|
increases expression |
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:6480464 |
CTD |
| G |
Rbm24 |
RNA binding motif protein 24 |
|
increases expression |
ISO |
17 |
24,217,930 |
24,229,736 |
RGD:6480464 |
CTD |
| G |
Rbp1 |
retinol binding protein 1, cellular |
|
increases expression |
EXP |
8 |
103,605,870 |
103,627,390 |
RGD:6480464 |
CTD |
| G |
Rbp1 |
retinol binding protein 1, cellular |
|
decreases expression |
ISO |
8 |
103,605,870 |
103,627,390 |
RGD:6480464 |
CTD |
| G |
Rbp2 |
retinol binding protein 2, cellular |
|
increases expression |
ISO |
8 |
103,665,461 |
103,685,771 |
RGD:6480464 |
CTD |
| G |
Reep5 |
receptor accessory protein 5 |
|
increases expression |
ISO |
18 |
26,813,889 |
26,845,178 |
RGD:6480464 |
CTD |
| G |
Rela |
v-rel reticuloendotheliosis viral oncogene homolog A (avian) |
|
increases activity |
ISO |
1 |
208,262,669 |
208,273,148 |
RGD:6480464 |
CTD |
| G |
Reln |
reelin |
|
increases expression |
ISO |
4 |
8,150,873 |
8,609,141 |
RGD:6480464 |
CTD |
| G |
Ren |
renin |
|
increases activity |
ISO |
13 |
46,262,936 |
46,275,213 |
RGD:6480464 |
CTD |
| G |
Resp18 |
regulated endocrine-specific protein 18 |
|
increases expression |
EXP |
9 |
74,551,809 |
74,558,151 |
RGD:6480464 |
CTD |
| G |
Rfc5 |
replication factor C (activator 1) 5 |
|
increases expression |
ISO |
12 |
40,395,942 |
40,405,498 |
RGD:6480464 |
CTD |
| G |
RGD1562114 |
RGD1562114 |
|
increases expression |
EXP |
7 |
11,043,998 |
11,045,708 |
RGD:6480464 |
CTD |
| G |
RGD1562658 |
similar to RIKEN cDNA 1700009P17 |
|
decreases expression |
ISO |
13 |
86,995,646 |
87,012,470 |
RGD:6480464 |
CTD |
| G |
RGD1564340 |
similar to hypothetical protein MGC5356 |
|
decreases expression |
ISO |
3 |
170,360,693 |
170,363,112 |
RGD:6480464 |
CTD |
| G |
RGD1566118 |
RGD1566118 |
|
increases expression |
EXP |
20 |
3,959,539 |
3,964,122 |
RGD:6480464 |
CTD |
| G |
Rgs10 |
regulator of G-protein signaling 10 |
|
increases expression |
ISO |
1 |
187,622,488 |
187,664,295 |
RGD:6480464 |
CTD |
| G |
Rheb |
Ras homolog enriched in brain |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rnf4 |
ring finger protein 4 |
|
increases expression |
ISO |
14 |
82,092,024 |
82,112,036 |
RGD:6480464 |
CTD |
| G |
Rnf4 |
ring finger protein 4 |
|
multiple interactions |
ISO |
14 |
82,092,024 |
82,112,036 |
RGD:6480464 |
CTD |
| G |
Rpa3 |
replication protein A3 |
|
increases expression |
ISO |
4 |
33,304,334 |
33,307,365 |
RGD:6480464 |
CTD |
| G |
Rpl10 |
ribosomal protein L10 |
|
increases expression |
EXP |
X |
160,336,632 |
160,338,842 |
RGD:6480464 |
CTD |
| G |
Rpl10a |
ribosomal protein L10A |
|
increases expression |
EXP |
20 |
6,569,083 |
6,571,641 |
RGD:6480464 |
CTD |
| G |
Rpl13 |
ribosomal protein L13 |
|
increases expression |
EXP |
19 |
53,437,633 |
53,440,184 |
RGD:6480464 |
CTD |
| G |
Rpl15 |
ribosomal protein L15 |
|
increases expression |
EXP |
15 |
9,082,190 |
9,085,473 |
RGD:6480464 |
CTD |
| G |
Rpl17 |
ribosomal protein L17 |
|
increases expression |
EXP |
18 |
71,863,062 |
71,866,168 |
RGD:6480464 |
CTD |
| G |
Rpl23 |
ribosomal protein L23 |
|
increases expression |
EXP |
10 |
86,527,589 |
86,531,549 |
RGD:6480464 |
CTD |
| G |
Rpl8 |
ribosomal protein L8 |
|
increases expression |
EXP |
7 |
114,954,061 |
114,956,339 |
RGD:6480464 |
CTD |
| G |
Rpn2 |
ribophorin II |
|
increases expression |
EXP |
3 |
147,976,544 |
148,023,743 |
RGD:6480464 |
CTD |
| G |
Rps15a |
ribosomal protein S15a |
|
increases expression |
EXP |
1 |
176,321,901 |
176,327,789 |
RGD:6480464 |
CTD |
| G |
Rps19 |
ribosomal protein S19 |
|
increases expression |
ISO |
1 |
80,176,649 |
80,182,351 |
RGD:6480464 |
CTD |
| G |
Rps19 |
ribosomal protein S19 |
|
increases expression |
EXP |
1 |
80,176,649 |
80,182,351 |
RGD:6480464 |
CTD |
| G |
Rps24 |
ribosomal protein S24 |
|
increases expression |
EXP |
16 |
43,766 |
48,353 |
RGD:6480464 |
CTD |
| G |
Rps27l |
ribosomal protein S27-like |
|
increases expression |
EXP |
|
|
|
RGD:6480464 |
CTD |
| G |
Rps3 |
ribosomal protein S3 |
|
increases expression |
EXP |
1 |
156,811,470 |
156,816,770 |
RGD:6480464 |
CTD |
| G |
Rps3a |
ribosomal protein S3a |
|
increases expression |
ISO |
2 |
178,092,351 |
178,096,720 |
RGD:6480464 |
CTD |
| G |
Rps4x |
ribosomal protein S4, X-linked |
|
increases expression |
EXP |
X |
34,793,683 |
34,794,576 |
RGD:6480464 |
CTD |
| G |
Rps7 |
ribosomal protein S7 |
|
increases expression |
EXP |
6 |
46,511,961 |
46,516,825 |
RGD:6480464 |
CTD |
| G |
Rpsa |
ribosomal protein SA |
|
increases expression |
EXP |
8 |
125,100,239 |
125,104,096 |
RGD:6480464 |
CTD |
| G |
Rptn |
repetin |
|
increases expression |
ISO |
2 |
186,483,053 |
186,487,110 |
RGD:6480464 |
CTD |
| G |
RT1-CE7 |
RT1 class I, locus CE7 |
|
decreases expression |
ISO |
20 |
3,410,094 |
3,413,041 |
RGD:6480464 |
CTD |
| G |
Runx1 |
runt-related transcription factor 1 |
|
decreases expression |
ISO |
11 |
32,623,461 |
32,725,404 |
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 |
|
increases expression |
EXP |
2 |
182,895,080 |
182,896,305 |
RGD:6480464 |
CTD |
| G |
S100a6 |
S100 calcium binding protein A6 |
|
decreases expression |
EXP |
2 |
182,895,080 |
182,896,305 |
RGD:6480464 |
CTD |
| G |
S100a8 |
S100 calcium binding protein A8 |
|
decreases expression |
ISO |
2 |
182,961,994 |
182,962,513 |
RGD:6480464 |
CTD |
| G |
S100g |
S100 calcium binding protein G |
|
decreases expression |
ISO |
X |
52,446,817 |
52,449,342 |
RGD:6480464 |
CTD |
| G |
S100g |
S100 calcium binding protein G |
|
decreases expression |
EXP |
X |
52,446,817 |
52,449,342 |
RGD:6480464 |
CTD |
| G |
S100g |
S100 calcium binding protein G |
|
increases expression |
EXP |
X |
52,446,817 |
52,449,342 |
RGD:6480464 |
CTD |
| G |
S1pr3 |
sphingosine-1-phosphate receptor 3 |
|
increases expression |
ISO |
17 |
19,657,822 |
19,661,106 |
RGD:6480464 |
CTD |
| G |
Sat1 |
spermidine/spermine N1-acetyl transferase 1 |
|
increases expression |
ISO |
X |
61,634,964 |
61,638,247 |
RGD:6480464 |
CTD |
| G |
Scarb2 |
scavenger receptor class B, member 2 |
|
increases expression |
ISO |
14 |
17,119,366 |
17,170,850 |
RGD:6480464 |
CTD |
| G |
Scx |
scleraxis |
|
increases expression |
ISO |
7 |
114,504,701 |
114,506,719 |
RGD:6480464 |
CTD |
| G |
Sdc2 |
syndecan 2 |
|
increases expression |
EXP |
7 |
68,290,558 |
68,405,183 |
RGD:6480464 |
CTD |
| G |
Sdf2 |
stromal cell derived factor 2 |
|
decreases expression |
ISO |
10 |
64,378,703 |
64,389,178 |
RGD:6480464 |
CTD |
| G |
Selenbp1 |
selenium binding protein 1 |
|
decreases expression |
ISO |
2 |
189,840,450 |
189,881,332 |
RGD:6480464 |
CTD |
| G |
Sepw1 |
selenoprotein W, 1 |
|
increases expression |
EXP |
1 |
76,249,869 |
76,254,942 |
RGD:6480464 |
CTD |
| G |
Serpina1f |
serine (or cysteine) peptidase inhibitor, clade A, member 1F |
|
decreases expression |
ISO |
6 |
127,952,484 |
127,958,689 |
RGD:6480464 |
CTD |
| G |
Serpina3n |
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
|
increases expression |
ISO |
6 |
128,461,775 |
128,469,309 |
RGD:6480464 |
CTD |
| G |
Serpinb2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
|
increases expression |
ISO |
13 |
13,632,596 |
13,641,605 |
RGD:6480464 |
CTD |
| G |
Serpinb3a |
serine (or cysteine) peptidase inhibitor, clade B (ovalbumin), member 3A |
|
increases expression |
ISO |
13 |
13,305,950 |
13,311,099 |
RGD:6480464 |
CTD |
| G |
Serpinb5 |
serpin peptidase inhibitor, clade B (ovalbumin), member 5 |
|
increases expression |
ISO |
13 |
13,037,587 |
13,057,785 |
RGD:6480464 |
CTD |
| G |
Sez6 |
seizure related 6 homolog (mouse) |
|
increases expression |
EXP |
10 |
63,994,947 |
64,021,007 |
RGD:6480464 |
CTD |
| G |
Sf3b4 |
splicing factor 3b, subunit 4 |
|
increases expression |
EXP |
2 |
190,976,681 |
190,981,433 |
RGD:6480464 |
CTD |
| G |
Sfn |
stratifin |
|
increases expression |
ISO |
5 |
151,475,395 |
151,479,996 |
RGD:6480464 |
CTD |
| G |
Sfrp4 |
secreted frizzled-related protein 4 |
|
increases expression |
ISO |
17 |
53,121,425 |
53,131,507 |
RGD:6480464 |
CTD |
| G |
Sh3gl3 |
SH3-domain GRB2-like 3 |
|
increases expression |
ISO |
1 |
138,398,336 |
138,529,056 |
RGD:6480464 |
CTD |
| G |
Shisa5 |
shisa homolog 5 (Xenopus laevis) |
|
increases expression |
ISO |
8 |
114,068,670 |
114,071,301 |
RGD:6480464 |
CTD |
| G |
Siah2 |
siah E3 ubiquitin protein ligase 2 |
|
increases expression |
ISO |
2 |
148,022,641 |
148,040,390 |
RGD:6480464 |
CTD |
| G |
Six1 |
SIX homeobox 1 |
|
increases expression |
ISO |
6 |
95,470,153 |
95,475,389 |
RGD:6480464 |
CTD |
| G |
Six1 |
SIX homeobox 1 |
|
decreases expression |
ISO |
6 |
95,470,153 |
95,475,389 |
RGD:6480464 |
CTD |
| G |
Skap2 |
src kinase associated phosphoprotein 2 |
|
increases expression |
ISO |
4 |
80,149,846 |
80,300,111 |
RGD:6480464 |
CTD |
| G |
Slc12a2 |
solute carrier family 12 (sodium/potassium/chloride transporters), member 2 |
|
decreases expression |
ISO |
18 |
53,673,215 |
53,741,352 |
RGD:6480464 |
CTD |
| G |
Slc12a7 |
solute carrier family 12 (potassium/chloride transporters), member 7 |
|
increases expression |
EXP |
1 |
30,281,826 |
30,334,183 |
RGD:6480464 |
CTD |
| G |
Slc25a30 |
solute carrier family 25, member 30 |
|
increases expression |
EXP |
15 |
56,656,204 |
56,695,237 |
RGD:6480464 |
CTD |
| G |
Slc29a1 |
solute carrier family 29 (nucleoside transporters), member 1 |
|
decreases expression |
ISO |
9 |
11,000,054 |
11,014,914 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
decreases activity |
ISO |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Slc2a1 |
solute carrier family 2 (facilitated glucose transporter), member 1 |
|
multiple interactions |
ISO |
5 |
139,690,801 |
139,719,021 |
RGD:6480464 |
CTD |
| G |
Slc38a4 |
solute carrier family 38, member 4 |
|
increases expression |
EXP |
7 |
135,693,013 |
135,750,703 |
RGD:6480464 |
CTD |
| G |
Slc39a4 |
solute carrier family 39 (zinc transporter), member 4 |
|
decreases expression |
ISO |
7 |
114,661,925 |
114,666,098 |
RGD:6480464 |
CTD |
| G |
Slc39a4 |
solute carrier family 39 (zinc transporter), member 4 |
|
increases expression |
ISO |
7 |
114,661,925 |
114,666,098 |
RGD:6480464 |
CTD |
| G |
Slc39a8 |
solute carrier family 39 (zinc transporter), member 8 |
|
increases expression |
ISO |
2 |
233,340,397 |
233,403,461 |
RGD:6480464 |
CTD |
| G |
Slc3a2 |
solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2 |
|
increases expression |
ISO |
1 |
211,375,889 |
211,390,313 |
RGD:6480464 |
CTD |
| G |
Slc44a4 |
solute carrier family 44, member 4 |
|
increases expression |
ISO |
20 |
4,005,154 |
4,021,270 |
RGD:6480464 |
CTD |
| G |
Slc6a14 |
solute carrier family 6 (amino acid transporter), member 14 |
|
increases expression |
ISO |
X |
12,048,993 |
12,072,434 |
RGD:6480464 |
CTD |
| G |
Slc6a20 |
solute carrier family 6 (proline IMINO transporter), member 20 |
|
increases expression |
EXP |
8 |
128,412,080 |
128,452,212 |
RGD:6480464 |
CTD |
| G |
Slc6a6 |
solute carrier family 6 (neurotransmitter transporter, taurine), member 6 |
|
increases expression |
ISO |
4 |
125,875,817 |
125,945,795 |
RGD:6480464 |
CTD |
| G |
Slc7a11 |
solute carrier family 7 (anionic amino acid transporter light chain, xc- system), member 11 |
|
increases expression |
ISO |
2 |
139,241,142 |
139,317,101 |
RGD:6480464 |
CTD |
| G |
Slc7a5 |
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
|
increases expression |
ISO |
19 |
52,120,728 |
52,149,332 |
RGD:6480464 |
CTD |
| G |
Slc7a6os |
solute carrier family 7, member 6 opposite strand |
|
increases expression |
EXP |
19 |
36,051,094 |
36,059,755 |
RGD:6480464 |
CTD |
| G |
Slc9a3r1 |
solute carrier family 9, subfamily A (NHE3, cation proton antiporter 3), member 3 regulator 1 |
|
increases expression |
ISO |
10 |
105,237,637 |
105,254,750 |
RGD:6480464 |
CTD |
| G |
Smad2 |
SMAD family member 2 |
|
decreases phosphorylation |
ISO |
18 |
73,180,520 |
73,241,707 |
RGD:6480464 |
CTD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
decreases expression |
EXP |
4 |
89,613,731 |
89,722,807 |
RGD:6480464 |
CTD |
| G |
Socs2 |
suppressor of cytokine signaling 2 |
|
decreases expression |
ISO |
7 |
32,605,714 |
32,608,323 |
RGD:6480464 |
CTD |
| G |
Sostdc1 |
sclerostin domain containing 1 |
|
decreases expression |
EXP |
6 |
55,066,277 |
55,070,451 |
RGD:6480464 |
CTD |
| G |
Sostdc1 |
sclerostin domain containing 1 |
|
increases expression |
EXP |
6 |
55,066,277 |
55,070,451 |
RGD:6480464 |
CTD |
| G |
Sox17 |
SRY (sex determining region Y)-box 17 |
|
increases expression |
ISO |
5 |
15,241,405 |
15,246,904 |
RGD:6480464 |
CTD |
| G |
Sox2 |
SRY (sex determining region Y)-box 2 |
|
decreases expression |
EXP |
2 |
120,969,021 |
120,971,430 |
RGD:6480464 |
CTD |
| G |
Sp1 |
Sp1 transcription factor |
|
increases expression |
ISO |
7 |
141,164,180 |
141,194,509 |
RGD:6480464 |
CTD |
| G |
Spink4 |
serine peptidase inhibitor, Kazal type 4 |
|
increases expression |
EXP |
5 |
58,314,305 |
58,325,973 |
RGD:6480464 |
CTD |
| G |
Spon1 |
spondin 1, extracellular matrix protein |
|
increases expression |
EXP |
1 |
171,700,495 |
172,020,808 |
RGD:6480464 |
CTD |
| G |
Spp1 |
secreted phosphoprotein 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Spred2 |
sprouty-related, EVH1 domain containing 2 |
|
decreases expression |
ISO |
14 |
100,775,869 |
100,797,717 |
RGD:6480464 |
CTD |
| G |
Sprr1a |
small proline-rich protein 1A |
|
increases expression |
ISO |
2 |
185,463,951 |
185,465,849 |
RGD:6480464 |
CTD |
| G |
Sprr1b |
small proline-rich protein 1B |
|
increases expression |
ISO |
2 |
185,418,131 |
185,418,568 |
RGD:6480464 |
CTD |
| G |
Sprr3 |
small proline-rich protein 3 |
|
increases expression |
ISO |
2 |
185,436,598 |
185,437,356 |
RGD:6480464 |
CTD |
| G |
Spsb1 |
splA/ryanodine receptor domain and SOCS box containing 1 |
|
increases expression |
ISO |
5 |
167,014,271 |
167,025,579 |
RGD:6480464 |
CTD |
| G |
Sptlc2 |
serine palmitoyltransferase, long chain base subunit 2 |
|
increases expression |
ISO |
6 |
111,546,037 |
111,622,959 |
RGD:6480464 |
CTD |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
increases expression |
EXP |
3 |
148,157,256 |
148,170,524 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
EXP |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Star |
steroidogenic acute regulatory protein |
|
decreases expression |
ISO |
16 |
70,642,580 |
70,647,203 |
RGD:6480464 |
CTD |
| G |
Stard3 |
StAR-related lipid transfer (START) domain containing 3 |
|
increases expression |
ISO |
10 |
87,132,237 |
87,160,076 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
increases expression |
ISO |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Stat1 |
signal transducer and activator of transcription 1 |
|
increases expression |
EXP |
9 |
46,455,635 |
46,497,560 |
RGD:6480464 |
CTD |
| G |
Stat3 |
signal transducer and activator of transcription 3 (acute-phase response factor) |
|
increases expression |
ISO |
10 |
89,821,078 |
89,872,970 |
RGD:6480464 |
CTD |
| G |
Stat5a |
signal transducer and activator of transcription 5A |
|
increases expression |
ISO |
10 |
89,795,404 |
89,819,732 |
RGD:6480464 |
CTD |
| G |
Stmn1 |
stathmin 1 |
|
increases expression |
EXP |
5 |
153,226,420 |
153,232,084 |
RGD:6480464 |
CTD |
| G |
Stx1a |
syntaxin 1A (brain) |
|
decreases expression |
EXP |
12 |
22,737,112 |
22,765,064 |
RGD:6480464 |
CTD |
| G |
Sult1e1 |
sulfotransferase family 1E, estrogen-preferring, member 1 |
|
decreases activity |
ISO |
14 |
21,948,475 |
21,965,541 |
RGD:6480464 |
CTD |
| G |
Tacstd2 |
tumor-associated calcium signal transducer 2 |
|
increases expression |
ISO |
4 |
97,803,151 |
97,804,851 |
RGD:6480464 |
CTD |
| G |
Tank |
TRAF family member-associated NFKB activator |
|
increases expression |
EXP |
3 |
43,396,247 |
43,475,491 |
RGD:6480464 |
CTD |
| G |
Tat |
tyrosine aminotransferase |
|
increases expression |
EXP |
19 |
39,854,163 |
39,865,060 |
RGD:6480464 |
CTD |
| G |
Tbc1d1 |
TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1 |
|
decreases expression |
ISO |
14 |
46,594,874 |
46,781,813 |
RGD:6480464 |
CTD |
| G |
Tcf21 |
transcription factor 21 |
|
decreases expression |
ISO |
1 |
23,211,054 |
23,213,913 |
RGD:6480464 |
CTD |
| G |
Tcf21 |
transcription factor 21 |
|
decreases expression |
EXP |
1 |
23,211,054 |
23,213,913 |
RGD:6480464 |
CTD |
| G |
Tcf21 |
transcription factor 21 |
|
increases expression |
EXP |
1 |
23,211,054 |
23,213,913 |
RGD:6480464 |
CTD |
| G |
Tcf3 |
transcription factor 3 |
|
decreases expression |
ISO |
7 |
10,791,311 |
10,813,613 |
RGD:6480464 |
CTD |
| G |
Tcf4 |
transcription factor 4 |
|
increases expression |
EXP |
18 |
66,135,863 |
66,359,984 |
RGD:6480464 |
CTD |
| G |
Tfcp2l1 |
transcription factor CP2-like 1 |
|
decreases expression |
ISO |
13 |
31,288,228 |
31,401,482 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
multiple interactions |
ISO |
20 |
9,526,674 |
9,530,534 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
increases expression |
ISO |
20 |
9,526,674 |
9,530,534 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
multiple interactions |
ISO |
20 |
9,526,674 |
9,530,534 |
RGD:6480464 |
CTD |
| G |
Tff1 |
trefoil factor 1 |
|
increases expression |
ISO |
20 |
9,526,674 |
9,530,534 |
RGD:6480464 |
CTD |
| G |
Tff2 |
trefoil factor 2 |
|
increases expression |
EXP |
20 |
9,492,341 |
9,510,558 |
RGD:6480464 |
CTD |
| G |
Tff3 |
trefoil factor 3, intestinal |
|
multiple interactions |
ISO |
20 |
9,469,888 |
9,474,604 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
increases expression |
ISO |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfa |
transforming growth factor alpha |
|
increases expression |
ISO |
4 |
120,355,649 |
120,437,772 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
multiple interactions |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
decreases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
increases expression |
EXP |
1 |
80,894,705 |
80,911,020 |
RGD:6480464 |
CTD |
| G |
Tgfb3 |
transforming growth factor, beta 3 |
|
increases expression |
ISO |
6 |
110,173,443 |
110,195,215 |
RGD:6480464 |
CTD |
| G |
Thbs1 |
thrombospondin 1 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Timm10b |
translocase of inner mitochondrial membrane 10 homolog B |
|
increases expression |
EXP |
1 |
163,369,731 |
163,372,577 |
RGD:6480464 |
CTD |
| G |
Timp1 |
TIMP metallopeptidase inhibitor 1 |
|
increases expression |
EXP |
X |
12,542,496 |
12,547,094 |
RGD:6480464 |
CTD |
| G |
Tmed4 |
transmembrane emp24 protein transport domain containing 4 |
|
increases expression |
EXP |
14 |
86,997,282 |
87,001,869 |
RGD:6480464 |
CTD |
| G |
Tmsb10 |
thymosin, beta 10 |
|
decreases expression |
ISO |
4 |
106,286,030 |
106,287,089 |
RGD:6480464 |
CTD |
| G |
Tnf |
tumor necrosis factor |
|
increases expression |
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:6480464 |
CTD |
| G |
Tnfrsf25 |
tumor necrosis factor receptor superfamily, member 25 |
|
increases expression |
ISO |
5 |
169,344,695 |
169,348,961 |
RGD:6480464 |
CTD |
| G |
Tnfrsf25 |
tumor necrosis factor receptor superfamily, member 25 |
|
decreases expression |
ISO |
5 |
169,344,695 |
169,348,961 |
RGD:6480464 |
CTD |
| G |
Tnfrsf9 |
tumor necrosis factor receptor superfamily, member 9 |
|
increases expression |
ISO |
5 |
168,071,159 |
168,099,501 |
RGD:6480464 |
CTD |
| G |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
|
increases expression |
ISO |
2 |
113,204,303 |
113,221,550 |
RGD:6480464 |
CTD |
| G |
Tnfsf14 |
tumor necrosis factor (ligand) superfamily, member 14 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnfsf9 |
tumor necrosis factor (ligand) superfamily, member 9 |
|
increases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tnk2 |
tyrosine kinase, non-receptor, 2 |
|
increases expression |
ISO |
11 |
69,927,509 |
69,966,854 |
RGD:6480464 |
CTD |
| G |
Tnnt2 |
troponin T type 2 (cardiac) |
|
decreases expression |
ISO |
13 |
48,872,972 |
48,885,815 |
RGD:6480464 |
CTD |
| G |
Tob1 |
transducer of ErbB-2.1 |
|
increases expression |
ISO |
10 |
82,852,405 |
82,854,443 |
RGD:6480464 |
CTD |
| G |
Top2a |
topoisomerase (DNA) II alpha |
|
increases expression |
EXP |
10 |
87,771,337 |
87,800,960 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
multiple interactions |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
decreases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
EXP |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
affects response to substance |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53 |
tumor protein p53 |
|
increases expression |
ISO |
10 |
56,399,721 |
56,411,150 |
RGD:6480464 |
CTD |
| G |
Tp53inp2 |
tumor protein p53 inducible nuclear protein 2 |
|
increases expression |
ISO |
3 |
145,878,005 |
145,886,088 |
RGD:6480464 |
CTD |
| G |
Tpd52l2 |
tumor protein D52-like 2 |
|
increases expression |
EXP |
3 |
170,631,625 |
170,650,377 |
RGD:6480464 |
CTD |
| G |
Tpp1 |
tripeptidyl peptidase I |
|
increases expression |
EXP |
1 |
163,490,394 |
163,496,517 |
RGD:6480464 |
CTD |
| G |
Traf3 |
Tnf receptor-associated factor 3 |
|
increases expression |
ISO |
6 |
135,925,375 |
136,027,270 |
RGD:6480464 |
CTD |
| G |
Tsc2 |
tuberous sclerosis 2 |
|
increases response to substance |
EXP |
10 |
13,848,210 |
13,883,189 |
RGD:6480464 |
CTD |
| G |
Tspan8 |
tetraspanin 8 |
|
increases expression |
ISO |
7 |
55,104,257 |
55,136,906 |
RGD:6480464 |
CTD |
| G |
Tubb4a |
tubulin, beta 4A class IVa |
|
decreases expression |
ISO |
|
|
|
RGD:6480464 |
CTD |
| G |
Tubb5 |
tubulin, beta 5 class I |
|
increases expression |
EXP |
20 |
3,060,224 |
3,090,776 |
RGD:6480464 |
CTD |
| G |
Tyms |
thymidylate synthetase |
|
increases expression |
EXP |
9 |
112,604,912 |
112,617,706 |
RGD:6480464 |
CTD |
| G |
Ubl3 |
ubiquitin-like 3 |
|
increases expression |
ISO |
12 |
7,019,485 |
7,063,818 |
RGD:6480464 |
CTD |
| G |
Ugt2b17 |
UDP glucuronosyltransferase 2 family, polypeptide B17 |
|
increases glucuronidation |
EXP |
14 |
22,639,182 |
22,650,931 |
RGD:6480464 |
CTD |
| G |
Uox |
urate oxidase |
|
increases expression |
ISO |
2 |
244,795,552 |
244,832,143 |
RGD:6480464 |
CTD |
| G |
Vamp3 |
vesicle-associated membrane protein 3 |
|
decreases expression |
EXP |
5 |
168,190,569 |
168,201,165 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
multiple interactions |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
increases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vegfa |
vascular endothelial growth factor A |
|
decreases expression |
EXP |
9 |
10,520,730 |
10,536,071 |
RGD:6480464 |
CTD |
| G |
Vip |
vasoactive intestinal peptide |
|
multiple interactions |
EXP |
1 |
36,361,513 |
36,369,594 |
RGD:6480464 |
CTD |
| G |
Vip |
vasoactive intestinal peptide |
|
increases expression |
EXP |
1 |
36,361,513 |
36,369,594 |
RGD:6480464 |
CTD |
| G |
Vip |
vasoactive intestinal peptide |
|
increases expression |
EXP |
1 |
36,361,513 |
36,369,594 |
RGD:6480464 |
CTD |
| G |
Vit |
vitrin |
|
decreases expression |
ISO |
6 |
1,319,479 |
1,399,647 |
RGD:6480464 |
CTD |
| G |
Vnn1 |
vanin 1 |
|
decreases expression |
ISO |
1 |
22,087,290 |
22,097,592 |
RGD:6480464 |
CTD |
| G |
Vsx2 |
visual system homeobox 2 |
|
multiple interactions |
EXP |
6 |
108,638,063 |
108,660,830 |
RGD:6480464 |
CTD |
| G |
Wars |
tryptophanyl-tRNA synthetase |
|
increases expression |
ISO |
6 |
133,200,866 |
133,232,048 |
RGD:6480464 |
CTD |
| G |
Wfdc1 |
WAP four-disulfide core domain 1 |
|
decreases expression |
ISO |
19 |
49,924,440 |
49,943,113 |
RGD:6480464 |
CTD |
| G |
Wfdc12 |
WAP four-disulfide core domain 12 |
|
increases expression |
ISO |
3 |
155,130,095 |
155,130,444 |
RGD:6480464 |
CTD |
| G |
Wfdc16 |
WAP four-disulfide core domain 16 |
|
decreases expression |
ISO |
3 |
155,655,829 |
155,665,625 |
RGD:6480464 |
CTD |
| G |
Wfdc2 |
WAP four-disulfide core domain 2 |
|
increases expression |
ISO |
3 |
155,582,378 |
155,588,056 |
RGD:6480464 |
CTD |
| G |
Wfdc2 |
WAP four-disulfide core domain 2 |
|
decreases expression |
ISO |
3 |
155,582,378 |
155,588,056 |
RGD:6480464 |
CTD |
| G |
Wipi1 |
WD repeat domain, phosphoinositide interacting 1 |
|
increases expression |
EXP |
10 |
98,722,266 |
98,753,713 |
RGD:6480464 |
CTD |
| G |
Wnt2b |
wingless-type MMTV integration site family, member 2B |
|
increases expression |
ISO |
2 |
200,218,630 |
200,233,002 |
RGD:6480464 |
CTD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
affects expression |
ISO |
5 |
156,064,371 |
156,083,198 |
RGD:6480464 |
CTD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
increases expression |
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:6480464 |
CTD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
multiple interactions |
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:6480464 |
CTD |
| G |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
|
decreases expression |
ISO |
4 |
125,541,281 |
125,586,167 |
RGD:6480464 |
CTD |
| G |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
|
decreases expression |
ISO |
4 |
125,541,281 |
125,586,167 |
RGD:6480464 |
CTD |
| G |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
|
multiple interactions |
ISO |
4 |
125,541,281 |
125,586,167 |
RGD:6480464 |
CTD |
| G |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
|
multiple interactions |
ISO |
4 |
125,541,281 |
125,586,167 |
RGD:6480464 |
CTD |
| G |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
|
increases response to substance |
ISO |
4 |
125,541,281 |
125,586,167 |
RGD:6480464 |
CTD |
| G |
Wnt7a |
wingless-type MMTV integration site family, member 7A |
|
multiple interactions |
ISO |
4 |
125,541,281 |
125,586,167 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
increases expression |
ISO |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Xdh |
xanthine dehydrogenase |
|
decreases expression |
EXP |
6 |
21,417,685 |
21,590,015 |
RGD:6480464 |
CTD |
| G |
Ywhab |
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide |
|
increases expression |
ISO |
3 |
154,926,025 |
154,948,297 |
RGD:6480464 |
CTD |
| G |
Zeb1 |
zinc finger E-box binding homeobox 1 |
|
decreases expression |
ISO |
17 |
60,177,150 |
60,198,584 |
RGD:6480464 |
CTD |
| G |
Zfp161 |
zinc finger protein 161 |
|
decreases expression |
ISO |
9 |
108,512,808 |
108,514,157 |
RGD:6480464 |
CTD |
| G |
Zhx1 |
zinc fingers and homeoboxes 1 |
|
increases expression |
EXP |
7 |
94,753,899 |
94,775,384 |
RGD:6480464 |
CTD |
| G |
Zmat3 |
zinc finger, matrin type 3 |
|
increases expression |
EXP |
2 |
118,526,985 |
118,537,727 |
RGD:6480464 |
CTD |
| G |
Zmynd10 |
zinc finger, MYND-type containing 10 |
|
decreases expression |
ISO |
8 |
112,794,227 |
112,798,585 |
RGD:6480464 |
CTD |
Term paths to the root
|